Page last updated: 2024-09-03

pramipexole and Idiopathic Parkinson Disease

pramipexole has been researched along with Idiopathic Parkinson Disease in 387 studies

Research

Studies (387)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	32 (8.27)	18.2507
2000's	168 (43.41)	29.6817
2010's	154 (39.79)	24.3611
2020's	33 (8.53)	2.80

Authors

Authors	Studies
Gmeiner, P; Hübner, H; Stanek, M; Weichert, D	1
Dong, AQ; Li, D; Liu, CF; Mao, CJ; Ren, C; Wang, CT; Wang, F; Wei, SZ; Yao, XY; Zhang, JB; Zhang, YT	1
Jiang, DQ; Jiang, LL; Li, MX; Lu, CS; Wang, Y	1
Gencler, OS; Oztekin, MF; Oztekin, N	1
De Wit, LE; Egberts, TCG; Souverein, PC; van der Pol, P; Wilting, I	1
Brotchie, J; Friedman, H; Giladi, N; Hauser, RA; Litman, P; Oren, S; Poewe, W	1
Cui, B; Hu, Y; Pan, Y; Sun, Y; Ye, L	1
Cheng, S; Wang, Z	1
Cheng, XY; Dong, AQ; Hu, LF; Jiang, SM; Liu, CF; Mao, CJ; Qi, D; Wang, F; Yang, YP; Yao, XY	1
Mantovani, E; Tamburin, S	1
Chen, J; Liu, W; Liu, Z; Ning, H; Ren, J; Shen, L; Tian, Z; Wang, H; Wang, Z; Yang, N; Yuan, C; Zhao, Y; Zheng, H; Zhou, G; Zhou, H	1
Li, T; Liang, Z; Liu, M; Zhang, Z; Zou, S	1
Calandra-Buonaura, G; Contin, M; Cortelli, P; De Massis, P; Guarino, M; Lopane, G; Marini, L; Mohamed, S; Persichella, C; Sambati, L; Sermi, S	1
Chen, FF; Chen, XT; Wen, SY; Zhang, Q; Zhou, CQ	1
Artusi, CA; Bozzali, M; Covolo, A; Imbalzano, G; Ledda, C; Lopiano, L; Martone, T; Montanaro, E; Rizzone, MG; Romagnolo, A; Zibetti, M	1
Bácskay, I; Jójárt-Laczkovich, O; Kristó, K; Nemes, D; Pamlényi, K; Regdon, G	1
Chen, F; Chen, X; Wen, S; Zhang, Q; Zhou, C	1
Belloso-Iguerategui, A; Cotman, CW; Fernández-Irigoyen, J; Gago, B; Merino-Galan, L; Prieto, GA; Quiroga-Varela, A; Rodríguez-Chinchilla, T; Rodríguez-Oroz, MC; Santamaria, E; Zamarbide, M	1
Aktürk, T; Güntekin, B; Hanoğlu, L; Hanoğlu, T; Yulug, B	1
Martinez, E; Météreau, É; Pasquereau, B; Saga, Y; Tremblay, L	1
Bortolato, M; Jeon, N	1
Huang, P; Jiao, Z; Ke, M; Lin, C; Wu, W; Xu, J; You, X	1
Antonini, A; Durner, G; Falup-Pecurariu, C; Henriksen, T; Kessel, B; Martinez-Martin, P; Odin, P; Ray Chaudhuri, K; Rizos, A; Sauerbier, A; Silverdale, M	1
Adalid-Peralta, L; Álvarez-Luquin, D; Ángeles-Perea, S; Arce-Sillas, A; Boll, MC; Espinosa-Cárdenas, R; Fragoso, G; Garcia-Garcia, E; González-Saavedra, I; Leyva-Hernández, J; Montes-Moratilla, E; Sciutto, E	1
Ding, J; Hong, W; Huang, J; Ren, Y; Yang, Z	1
Daniels, RN; Whatley, MF; Wilson, SM; Wurst, MG	1
Bissoli, LB; Maia, RPD; Mello, LGM; Monteiro, MLR; Saraiva, FP	1
Abbasi, MH; Esmaeili, S; Habibi, SA; Shahidi, GA	1
Chantasart, D; Li, SK; Saepang, K	1
Gao, H; Jiang, S; Mao, JP; Wang, D; Wang, YL; Yang, XL	1
Jiang, DQ; Jiang, LL; Li, MX; Qiao, JY; Wang, Y; Zang, QM	1
Jiang, DQ; Jiang, LL; Li, MX; Wang, Y	1
Gao, H; Jiang, S; Li, P; Li, Y; Luo, Q; Yang, X; Yong, Y; Zhang, H	1
Ando, H; Doyu, M; Fujikake, A; Fukuoka, T; Hayashi, M; Ito, C; Izumi, M; Kawagashira, Y; Koide, H; Nakashima, K; Niwa, JI; Ogawa, K; Oiwa, H; Okada, Y; Taguchi, S; Tokui, K; Tsunoda, Y; Yasumoto, A; Yuasa, T	1
Elmer, L; Friedman, H; Giladi, N; Hauser, RA; Kadosh, S; Kieburtz, K; Klepiskaya, OS; Kreitzman, DL; Leinonen, M; Lew, MF; Linvah, N; Litman, P; Olanow, CW; Russell, DS; The P B Study Group, F	1
Ji, F; Jiang, R; Su, Z; Xue, R; Zhou, Y; Zhu, X; Zhuo, C	1
Clemm von Hohenberg, C; Dreßing, H	1
Shen, T; Ye, R; Zhang, B	1
Aguirre, C; Calvo, B; Del Pozo-Rodríguez, A; Domingo-Echaburu, S; García, M; Isla, A; Lertxundi, U; Marquínez, AC; Solinís, MÁ	1
Dardou, D; Durif, F; Fleurance, R; Gryshkova, V; Hafidi, A; Loiodice, S; McGhan, P; Nogueira da Costa, A	1
Park, D	2
Gaud, R; Raj, R; Sridhar, V; Wairkar, S	1
Castro-Martínez, XH; Feliz-Feliz, C; García-Ruiz, PJ; Hoenicka, J; Martínez-Castrillo, JC; Martínez-García, C; Martínez-Torres, I; Mata, M; Palau, F; Vela, L	1
Argyelan, M; DeLucia, I; Eidelberg, D; Fitzpatrick, T; Gluck, M; Herzallah, M; Moustafa, AA; Sako, W; Sarpal, D; Vo, A	1
Boguszewski, PM; Kosson, P; Motyl, J; Przykaza, Ł; Strosznajder, JB	1
Hudson A, L; Miranda C, M	1
Liu, X; Qi, L; Sang, Q; Sun, W; Sun, Y; Wang, L; Wang, W; Zhang, H	1
Sun, YQ; Teoh, HC; Xiang, W	1
Kong, D; Shen, Z	1
Doladé, NG; Figueras, A; García, GC; Lanteri, PF; Leguia, A	1
Ma, Y; Sui, D; Wang, L; Wang, Y; Xu, H; Yu, X; Zhang, P	1
Fujita, H; Hirata, K; Matsubara, T; Miyamoto, M; Nakamura, T; Suzuki, K	1
Acıbuca, A; Akbostancı, C; Efe, TH; Erken Pamukcu, H; Gerede Uludağ, DM; Sorgun, MH; Tekin Tak, B; Turhan, S	1
Baik, JS; Cho, J; Jeon, B; Kim, HT; Kim, JM; Kim, JW; Koh, SB; Kwon, OD; Lee, HW; Lee, JY; Ma, HI; Yoon, WT	1
Calandra-Buonaura, G; Capellari, S; Contin, M; Cortelli, P; De Massis, P; Lopane, G; Mohamed, S; Nassetti, S; Perrone, A; Riva, R; Sambati, L; Scaglione, C	1
Belloso-Iguerategui, A; Delgado-Alvarado, M; Fernagut, PO; Gago, B; Jiménez-Urbieta, H; Marin, C; Merino-Galán, L; Navalpotro-Gómez, I; Oregi, A; Quiroga-Varela, A; Rodríguez-Chinchilla, T; Rodríguez-Oroz, MC	1
Li, Y; Nie, K; Wang, L; Zhang, P; Zhang, Y	1
Capuano, A; Rafaniello, C; Rossi, F; Scavone, C; Sportiello, L; Stelitano, B	1
Cooper, J; Ni, X; Ning, Y; Parks, D; Refoios Camejo, R; Yi, B; Zhao, H	1
Fu, Z; Li, G; Li, S; Li, Y; Liu, J; Sun, F; Teng, L; Xu, F; Zhang, X	1
Akiyama, S; Doi, N; Maida, C; Miyamoto, E	1
Frampton, JE	2
Ertem, DH; Koksal, A; Maner, F	1
Sheehan, J; Thorpe, M; Wilson, L	1
Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ	1
Béhé, M; Depboylu, C; Hermanns, G; Höglinger, GU; Matusch, A; Maurer, L; Oertel, WH; Windolph, A	1
Benbir, G; Ertan, S; Ozekmekci, S	1
Hauser, RA	1
Albrecht, S; Barone, P; Comella, CL; Hsu, HH; Marek, K; Massey, DH; McDermott, MP; Mizuno, Y; Poewe, W; Rascol, O; Schapira, AH	1
Edelstyn, NM; Ellis, SJ; Mayes, AR; Shepherd, TA	1
Raju, B; Ramakrishna, K; Rao, RN; Sravan, B; Srinivas, R	1
Hatano, T; Hattori, N; Oyama, G; Shimo, Y; Takanashi, M	1
Jeon, BS; Kim, HJ; Kim, JM; Kim, JS; Kim, YE; Lee, JY; Yun, JY	1
Antonelli, F; Houle, S; Ko, JH; Lang, AE; Miyasaki, J; Ray, NJ; Strafella, AP; Valzania, F	1
Dong, J; Liu, J; Su, Y; Sun, S; Wang, L; Yan, P	1
Bandettini di Poggio, M; Bruno, C; Meschini, MC; Nesti, C; Santorelli, FM; Schenone, A	1
Grauer, SM; Hodgson, R; Hyde, LA	1
Gonzalez-Alegre, P; Lamichhane, D; Narayanan, NS	1
Alonso-Canovas, A; Garcia-Ruiz, PJ; Herranz Barcenas, A; Mahillo Fernandez, I; Martinez Castrillo, JC; Mata, M; Olmedilla Gonzalez, N; Sanchez Alonso, P; Vela, L	1
Carcenac, C; Carnicella, S; Drui, G; Duran, T; Favier, M; Savasta, M	1
Kalaria, DR; Kalia, YN; Merino, V; Patel, P; Patravale, VB	1
Elkins, GR; Ramsey, D; Yu, Y	1
Peng, GG; Wang, M; Zhang, JW; Zhou, CQ	1
Hattori, N	1
Barone, P; Busse, M; Debieuvre, C; Fraessdorf, M; Hauser, RA; Mizuno, Y; Poewe, W; Rascol, O; Schapira, AH	3
Berghauzen-Maciejewska, K; Dziubina, A; Głowacka, U; Kolasiewicz, W; Kuter, K; Ossowska, K; Wardas, J	1
Ozer, AY; Silindir, M	1
Bakım, B; Çelik, S; Günday Toker, Ö; Meriç, C; Pirdoğan, E; Tekin, A	1
Aquino, CC; Lang, AE; Mestre, T	1
Glenmullen, J; Mattison, DR; Moore, TJ	1
Kataoka, H; Ueno, S	1
Larson, ER	1
Berghauzen-Maciejewska, K; Głowacka, U; Kosmowska, B; Kuter, K; Ossowska, K; Wardas, J	1
Doyu, M; Ibi, T; Niwa, J; Taguchi, S	1
Bauer, L; Chung, SJ; Ikeda, J; Jeon, BS; Kim, JM; Kim, JW; Singh, P; Thierfelder, S	2
Fernández-Bobadilla, R; Gironell, A; Kulisevsky, J; Martínez-Horta, S; Pagonabarraga, J; Pascual-Sedano, B; Pérez-Pérez, J; Sierra, S	1
Fernández, E; Fresno, C; Gershanik, OS; Gomez, G; González, GA; Larramendy, C; Murer, MG; Saborido, MD; Spaans, F; Taravini, IR	1
Cao, ZH; Chen, HX; Ding, ZG; Song, JH; Zhang, GB; Zhou, PY	1
Chen, H; Guo, Y; Hao, H; Jia, F; Li, L; Wan, S; Zhang, J	1
Titova, NV	1
Cicero, CE; Mostile, G; Nicoletti, A; Zappia, M	1
Boulet, S; Carcenac, C; Carnicella, S; David, O; Krack, P; Magnard, R; Savasta, M; Vachez, Y	1
Contin, M; Mohamed, S; Riva, R	1
Antonini, A; Chaudhuri, KR; Durner, G; Falup-Pecurariu, C; Grilo, M; Henriksen, T; Kessel, B; Martinez-Martin, P; Odin, P; Rizos, A; Røkenes Karlsen, K; Sauerbier, A; Silverdale, M; Weintraub, D	1
Albert, NL; Bartenstein, P; Boetzel, K; Cumming, P; Deutschländer, A; Gildehaus, FJ; la Fougère, C; Xiong, G	1
Jain, S; Pandey, S	1
Liu, J; Qian, Y; Xiao, Q; Xu, S; Yang, X	1
Bortolato, M; Burgeno, LM; Devoto, P; Fowler, SC; Fox, AT; Godar, SC; Jarmolowicz, DP; Levant, B; Pes, R; Phillips, PE; Strathman, HJ	1
Chen, SD; Di, Q; Liu, CF; Liu, YM; Ren, Y; Shang, HF; Sun, SG; Wang, Y; Xiang, W; Zhu, SQ	1
Assis, F; Barbosa, IG; Christo, PP; de Souza, MS; Reis, HJ; Rocha, NP; Scalzo, PL; Teixeira, AL; Vieira, ÉLM	1
Adlard, PA; Castro-Hernández, J; Finkelstein, DI	1
Jain, S; Pandey, S; Sarma, N	1
Madigan, EJ	1
Iakhno, NN; Nodel', MR	1
Arbouw, ME; Egberts, TC; Guchelaar, HJ; Movig, KL; Neef, C; Poels, PJ; van Vugt, JP	1
Hong, CT; Lu, CJ; Sun, Y	1
Bares, M; Krajcovicová, L; Rektor, I; Rektorová, I	1
Antonini, A	1
Agrawal, P; Beversdorf, DQ; Kostyk, SK; Pederzolli, AS; Thomas, KM; Tivarus, ME	1
Fujimoto, K	1
Carrasco, E; Iranzo, A; Kumru, H; Marti, MJ; Santamaria, J; Tolosa, E; Valldeoriola, F	1
Petroianu, GA; Stegmeier-Petroianu, A	1
Letvinenko, IV; Mogil'naia, VI; Odinak, MM	1
Taguchi, Y; Takashima, S; Tanaka, K	1
Doi, K; Isono, T; Kawamura, T; Kitagawa, N; Kuno, S; Masaki, M; Mizuta, E; Oeda, T; Sawada, H; Taniguchi, S; Yaku, H; Yamamoto, K; Yutani, C	1
Arai, H; Hatta, K; Hattori, N; Ishikawa, K; Kamigaichi, R; Kubo, S; Mochizuki, H; Ogaki, K; Usui, C; Yokoyama, K	1
Audebert, C; Blin, O; Eusebio, A; Jouve, E; Micallef, J; Rey, M; Rouby, F; Tardieu, S	1
Kato, Y; Kawamata, J; Takahashi, R; Washida, K	1
Nijssen, PC; Weber, WE	1
Kulisevsky, J; Martinez-Corral, M; Pagonabarraga, J	1
Barone, P; Fruh, B; Houben, JJ; Koester, J; Leentjens, AF; Shephard, DT	1
Fujioka, S; Iwamoto, K; Kawamura, M; Nakajima, M; Ohno, H	1
Cannas, A; Floris, G; Marrosu, F; Marrosu, MG; Piga, M; Serra, A; Solla, P; Tacconi, P	1
Ahlskog, JE; Bostwick, JM; Bower, JH; Hecksel, KA; Stevens, SR	1
Fan, L; Hu, DL; Ji, W; Li, Z; Liu, J; Liu, YZ; Nie, LN; Ouyang, DS; Tang, BS; Wang, D; Yan, XX; Zhou, HH	1
Keränen, T; Kuusisto, H; Tuhkasaari, M	1
Bereczki, D; Bódi, N; Daw, N; Dibó, G; Gluck, MA; Kéri, S; Moustafa, A; Myers, CE; Nagy, H; Takáts, A	1
Caltagirone, C; Carlesimo, GA; Costa, A; Dell'Agnello, G; Peppe, A	1
Bloem, BR; Gerschlager, W	1
Arbouw, ME; Egberts, TC; Guchelaar, HJ; Movig, KL; Neef, C; Poels, PJ; van der Straaten, RJ; van Vugt, JP; Wessels, JA	1
Cho, JY; Cho, YJ; Hong, KS; Jeon, BS; Kim, HJ; Lee, DH; Park, SY; Seo, SY	1
Armand, C; Cochran, J; François, C; Haycox, A; Murteira, S	1
Artemova, IIu; Boĭko, AN; Ganzula, PA; Ismailov, AM; Ivanov, AK; Khozova, AA; Levin, OS; Lisenker, LN; Nesterova, OS; Otcheskaia, OV; Rotor, LD; Vdovichenko, TV; Zhuravleva, EIu	1
Ballanger, B; Lang, AE; Miyasaki, JM; Pellecchia, G; Strafella, AP; van Eimeren, T	1
Lyons, KE; Pahwa, R	1
Nodel', MR	2
Albrecht, S; Buerger, E	1
Hackett, RJ; Kellett, MW; Kobylecki, C; Odiyoor, M; Silverdale, MA	1
Khan, W; Rana, AQ	1
Brodsky, MA; Nutt, JG; Park, BS	1
Coburn, KL; Doonan, SM; Lauterbach, EC; Mendez, MF; Shillcutt, SD; Victoroff, J	1
Bienfait, KL; Dobkin, RD; Mark, MH; Menza, M	1
Harrison, C	1
Bergmann, L; Jost, WH	1
Buck, K; Buerger, E; Ferger, B; Koros, E; Shimasaki, M; Voehringer, P	1
Chwieduk, CM; Curran, MP	1
Artemova, IIu; Boĭko, AN; Ganzhula, PA; Ismailov, AM; Ivanov, AK; Khozova, AA; Levin, OS; Lisenker, LN; Nesterova, OS; Otcheskaia, OV; Rotor, LD; Vdovichenko, TV; Zhuravleva, EIu	1
Albrecht, S; Barone, P; Debieuvre, C; Massey, D; Poewe, W; Rascol, O; Tolosa, E; Weintraub, D	1
Fernandez, HH; Merello, M	1
Koester, J; Lang, AE; Potenza, MN; Siderowf, AD; Stacy, M; Voon, V; Weintraub, D; Whetteckey, J; Wunderlich, GR	1
Albrecht, S; Barone, P; Comella, CL; Marek, K; McDermott, MP; Mizuno, Y; Poewe, W; Rascol, O; Schapira, AH	1
Bozi, M; Christodoulou, C; Douzenis, A; Gasparinatos, G; Stamboulis, E; Stefanis, C; Stefanis, L; Stefanis, N	1
Guo, Y; Janokovic, J; Le, W; Li, C; Li, X; Xie, W	1
Klivényi, P; Vécsei, L	1
Bustamante, L; Miranda, M; Pérez, C; Slachevsky, A	1
Bosco, D; Bosco, F; Consoli, A; Plastino, M; Rotondo, A	1
Barone, P; Debieuvre, C; Hauser, RA; Mizuno, Y; Poewe, W; Rascol, O; Salin, L; Schapira, AH; Sohr, M	1
Barone, P; Haaksma, M; Hauser, RA; Juhel, N; Mizuno, Y; Poewe, W; Rascol, O; Salin, L; Schapira, AH	2
Perez Lloret, S; Rascol, O	1
Amboni, M; Barone, P; Grossi, D; Santangelo, G; Sorrentino, G; Verde, F; Vitale, C	1
Ahlskog, JE; Bower, JH; Graff-Radford, J; Josephs, KA	1
Abbruzzese, G; Antonini, A; Barone, P; Ceravolo, R; Fabbrini, G; Tinazzi, M	1
Kieburtz, K	1
Kitamura, Y	1
Rascol, O	1
Barone, P	2
Janszky, J; Kovacs, N; Nagy, F	1
Ahlskog, JE; Bower, JH; Fealey, RD; Hassan, A; Josephs, KA; Kumar, N; Matsumoto, JY	1
Arai, M	1
Abe, H; Baba, Y; Fukuyama, K; Higuchi, MA; Inoue, T; Uehara, Y; Yamada, T	1
Ahlskog, JE	1
Adam, JJ; Duits, A; Scholtissen, B; van Houdt, H; Visser-Vandewalle, V; Winogrodzka, A	1
Perez Lloret, S; Perez-Lloret, S; Rascol, O; Ratti, L; Rey, MV	1
Barone, P; Busse, M; Hauser, RA; Juhel, N; Mizuno, Y; Poewe, W; Rascol, O; Salin, L; Schapira, AH	1
Hametner, EM; Poewe, W; Seppi, K	2
Antonini, A; Calandrella, D	1
Bronzova, J; Ferreira, JJ; Goetz, CG; Stebbins, GT; Stocchi, F; Theeuwes, A; van de Witte, S	1
Hamaguchi, H; Kanda, F; Sekiguchi, K; Yasui, N	1
de Cerqueira, AC; Nardi, AE	1
Hashimoto, S; Hatano, T; Hattori, N; Hirata, K; Kamei, S; Matsumura, M; Miyamoto, M; Miyamoto, T; Morita, A; Nogawa, S; Okuma, Y; Takahashi, K; Utsumi, H; Watanabe, Y; Yamamoto, T; Yoshii, F	1
Buttarelli, FR; Campanelli, D; Fanciulli, A; Misasi, R; Pontieri, FR	1
Aizawa, H; Ayabe, M; Hauser, M; Kida, H; Miura, S; Nagasato, K; Nakajima, J; Noda, K; Taniwaki, T	1
Appu, S; Chin, W; Dowling, C; Harper, M; Katz, DJ; Pang, C; Tay, YK; Vukasin, F	1
Napier, TC; Rokosik, SL	1
Tarrants, ML; Zagmutt, FJ	1
Coon, EA; Laughlin, RS	1
Han, SH; Jeon, BS; Kim, HJ; Kim, SH	1
Harada, T; Horie, N; Ishizaki, F; Katsuoka, H; Nagakane, T; Nitta, K; Nitta, Y; Sasaki, T; Yamada, T; Yasumatsu, Y	1
Bini, V; Bortolato, M; Cannas, A; Marrosu, F; Puligheddu, M; Solla, P	1
Nishijima, K; Saito, S; Shioda, K	1
Lim, EC	1
Munhoz, RP; Teive, HA; Zavala, JA	1
Napier, TC; Riddle, JL; Rokosik, SL	1
Aalten, P; Drijgers, RL; Leentjens, AF; Tissingh, G; van Domburg, PH; Verhey, FR	1
Asmus, F; Kaut, O; Paus, S	1
Cervantes-Arriaga, A; Corona, T; Ojeda-López, C; Rodríguez-Violante, M	1
Daghem, M; Grosset, DG; Grosset, KA; Macphee, GJ; Newman, EJ; Nissen, T; Odin, P; Pal, G; Stewart, M	1
Dell'Aniello, S; Ernst, P; Renoux, C; Suissa, S	1
Abdolahi, A; Biglan, KM; Dorsey, ER; Killoran, A; Scoglio, N	1
Blin, O; Lancrenon, S; Pitel, S; Viallet, F	1
Agosti, V; Barone, P; Errico, D; Grossi, D; Santangelo, G; Sorrentino, G; Trojano, L; Vitale, C	1
Cannas, A; Corona, M; Marrosu, F; Marrosu, MG; Solla, P	1
Chen, JF; Eberly, S; Kamp, C; Lang, AE; McDermott, MP; Messing, S; Oakes, D; Schwarzschild, MA; Tanner, CM; Tennis, M; Togasaki, D; Wills, AM	1
Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H	1
Ahlskog, JE; Maraganore, DM; Uhl, GR; Uitti, RJ	1
Schulz, GM	1
Montgomery, EB	2
Brecht, HM; Kraus, PH; Lemke, MR; Reichmann, H	1
Gekht, AB	1
Crevenna, R; Homann, CN; Ivanic, G; Ott, E; Suppan, K; Wenzel, K	1
Schapira, AH	2
Jennings, D; Marek, K; Seibyl, J	1
Clarke, CE; Guttman, M	1
Reichmann, H	1
Kuhlmann, A; Müller, T; Przuntek, H	1
Bain, PG; Findley, LJ; Jeffs, JA; Navan, P; Pearce, RK	2
Berardelli, A; De Pandis, MF; Modugno, N; Ruggieri, S; Stocchi, F; Thomas, A; Vacca, L; Valente, M	1
Bergmans, P; Booij, J; Stoof, JC; van Royen, EA; Winogrodzka, A; Wolters, EC	1
Bassi, A; Boffa, L; Brusa, L; Caramia, MD; Peppe, A; Pierantozzi, M; Ruggieri, S; Stanzione, P; Stefani, A	1
Etminan, M; Gill, S; Samii, A	1
MacMahon, DG	1
Morrish, PK	1
Bares, M; Dostál, V; Ehler, E; Fanfrdlová, Z; Fiedler, J; Klajblová, H; Kulist'ák, P; Rektor, I; Rektorová, I; Ressner, P; Svátová, J; Urbánek, K; Velísková, J	1
Driver-Dunckley, E; Samanta, J; Stacy, M	1
Fleckenstein, AE; Hanson, GR; Rau, KS; Truong, JG	1
Inzelberg, R; Nisipeanu, P; Schechtman, E	1
Brecht, MH; Köster, J; Kraus, PH; Lemke, MR; Reichmann, H	1
Hasegawa, K; Kowa, H; Kuno, S; Mizuno, Y; Origasa, H; Yamamoto, M; Yanagisawa, N	1
Lu, CS; Mok, V; Shan, DE; Tsoi, TH; Wong, KS; Yang, CC	1
Finsterer, J; Gatterer, E; Stöllberger, C	1
Lang, AE; Razmy, A; Shapiro, CM	1
Krahn, M; Lang, A; Marras, C; Naglie, G; Tomlinson, G	1
Jankovic, J; Le, W; Pan, T	1
Chigir', IP; Fedorova, NV; Krivonos, OV	1
Linazasoro, G	1
Kohno, Y; Takeuchi, S	1
Alexander-Brown, B; Atassi, F; Barclay, L; Bennett, S; Berry, D; Biglan, K; Borchert, L; Brocht, A; Brown, D; Daigneault, S; DeAngelis, M; Dillon, S; Dobson, J; Evans, S; Factor, S; Fahn, S; Fontaine, D; Ford, B; Fussell, B; Hall, J; Hammerstad, J; Harrigan, M; Hodgeman, K; Holloway, RG; Hubble, J; Jankovic, J; Kamp, C; Kieburtz, K; Kurlan, R; Lang, A; LeWitt, P; Marek, K; McDermott, M; Miyasaki, J; Montgomery, A; Musch, B; O'Connell, C; Pahwa, R; Panisset, M; Pantella, C; Petsinger, G; Pfeiffer, B; Pfeiffer, R; Rainey, P; Rajput, A; Richard, K; Riley, D; Rodnitzky, R; Ross, T; Rost-Ruffner, E; Russell, DS; Seibyl, J; Shinaman, A; Shirley, T; Shoulson, I; Shults, C; Sime, E; Stacy, M; Standaert, D; Suchowersky, O; Sutherland, L; Tennis, M; Waters, C; Watts, A; Weeks, C; Weiner, W; Welsh, M; Wood, S; Wooten, F	1
Antonini, A; Belgrado, E; Bergonzi, P; Cutuli, D; Mucchiut, M	1
Grosset, D; Grosset, K; Macphee, G; Needleman, F	1
Cassel, W; Haja, D; Körner, Y; Krüger, HP; Meindorfner, C; Möller, JC; Oertel, WH; Stiasny-Kolster, K	1
Bara-Jimenez, W; Chase, TN; Dimitrova, T; Favit, A; Mouradian, MM; Sherzai, A	1
Borwege, S; Hagner, D; Joyce, JN; Ryoo, H; Woolsey, C	1
Bain, PG; Findley, LJ; Navan, P; Pearce, RK; Undy, MB	1
Köster, J; Möller, JC; Oertel, WH; Pezzoli, G; Provinciali, L	1
Boggie, DT; Chan, H; Delattre, ML; Morreale, AP; Plowman, BK; Schaefer, MG	1
Kurlan, R	1
Althoff, R; Jacobson, J; Martineau, RJ; Singh, A	1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C	1
Brecht, HM; Koester, J; Kraus, PH; Lemke, MR; Reichmann, H	1
Asanuma, M; Diaz-Corrales, FJ; Miyazaki, I; Ogawa, N; Shimizu, M; Tanaka, K	1
Gauthier, P; Jankovic, J; Manian, P; Tintner, R	1
Ginovart, N; Ko, F; McCormick, P; Seeman, P; Willeit, M	1
Ahlskog, JE; Bower, JH; Josephs, KA; Klos, KJ; Matsumoto, JY	1
Hosoya, T; Iida, R; Kobayashi, S; Kuriyama, S; Otsuka, Y; Tomita, M	1
Möller, JC; Oertel, WH	2
Stocchi, F	1
Dick, AW; Holloway, RG; Noyes, K	1
Brown, LA; Doan, J; Pellis, SM; Suchowersky, O; Whishaw, IQ	1
Bharmal, A; Lu, C; Suchowersky, O	1
Morgan, JC; Sethi, KD; Sharma, P	1
Antonini, A; Barone, P; Bracco, F; Marconi, R; Morgante, L; Musch, B; Scarzella, L; Zappia, M	1
Palmieri, A	1
Altamirano, L; Cools, R; D'Esposito, M	1
Klepac, N; Relja, M	1
Brecht, HM; Koester, J; Lemke, MR; Reichmann, H	1
Duda, JE; Goveas, J; Moberg, PJ; Morales, KH; Potenza, MN; Siderowf, AD; Stern, MB; Weintraub, D	1
Chigir', IP; Fedorova, NV	2
Kumru, H; Marti, MJ; Santamaria, J; Tolosa, E; Valldeoriola, F	1
Linazasoro, G; van Blercom, N	1
Bandini, F; Cocito, L; Pizzorno, M; Primavera, A	1
Cotsarelis, G; Gupta, R; Katz, KA; Seykora, JT	1
Fuhrmann, JT; Junghanns, S; Koch, R; Oelwein, C; Reichmann, H; Simonis, G; Storch, A; Strasser, RH	1
Akaike, A; Izumi, Y; Katsuki, H; Kume, T; Sawada, H; Shimohama, S; Yamamoto, N	1
Hauser, RA; McDermott, MP; Messing, S	1
Bagyeva, GKh; Illarioshkin, SN; Ivanova-Smolenskaia, IA; Karabanov, AV; Karpova, EA; Markova, ED; Nurmanova, ShA; Poleshchuk, VV; Polevaia, EV; Timerbaeva, SL; Zagorovskaia, TB	1
Anzellotti, F; Bonanni, L; D'Andreagiovanni, A; Di Iorio, A; Onofrj, M; Stocchi, F; Thomas, A; Varanese, S	1
Aiello, L; Camponi, V; Carratelli, D; Cortese, M; Dignazio, L; Felli, B; Masin, AM; Morocutti, C; Pacitti, MT; Scoyni, RM; Trani, I	1
Dewey, RB; O'Suilleabhain, PE; Reimold, SC	1
Fisman, DN; Kleiner-Fisman, G	1
Alonso-Navarro, H; Jiménez-Jiménez, FJ	1
Boroojerdi, B; Martignoni, E; Oertel, WH; Poewe, WH; Quinn, N; Rascol, O; Rupp, M; Tolosa, E	1
Constantinescu, R; Kamp, C; Kieburtz, K; McDermott, MP; Romer, M	1
Senol, MG; Togrol, RE	1
Biglan, KM; Holloway, RG; McDermott, MP; Richard, IH	1
Hirai, T; Inoue, K; Ito, Y; Kurita, A; Oka, H; Sakamoto, T; Suzuki, M	1
Aiken, CB	1
Gugger, JJ; Wagner, ML	1
Bigal, ME; Rodrigues, GG; Speciali, JG; Stuginski-Barbosa, J	1
Brown, LA; Geda, YE; Imamura, A; Slowinski, J; Uitti, RJ; Wszolek, ZK	1
Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K	1
Hwang, JP; Li, CT; Tsai, SJ	1
Becker, N; Fabiani, G; Munhoz, RP; Teive, HAG	1
Camacho-Ochoa, M; Evans, DL; Piercey, MF; Walker, EL	1
Cutler, NR; Elvin, A; Friedman, J; Goetz, C; Hubble, JP; Koller, WC; Korts, D; Ranhosky, A; Sramek, JJ	1
Rabey, JM	1
Brown, D; Factor, SA; Molho, ES; Sanchez-Ramos, JR; Sheldon, C; Shulman, L; Singer, C; Weiner, WJ	1
Korts, D; Lieberman, A; Ranhosky, A	1
Heins, JR	1
Bennett, JP; Friedman, JH; Shannon, KM	1
Alldredge, BK; Aminoff, MJ; Bainbridge, JL; Dowling, GA; Gottwald, MD	1
Guttman, M	1
LeWitt, PA	2
Force, RW; Ting, RM	1
Dooley, M; Markham, A	1
Fernandez, HH; Friedman, JH	1
Yamamoto, M	1
Lange, KW	1
Davies, R; Friedman, JH; Jacques, C	1
Factor, SA	1
Oertel, WH; Pinter, MM; Pogarell, O	1
Blasucci, L; Goetz, CG; Stebbins, GT	1
Cummings, JL	1
Bennett, JP; Piercey, MF	1
Bala, MV; Chrischilles, EA; Greer, M; Hoerger, TJ; Holloway, RG; Rowland, C	1
Fahn, S; Frucht, S; Gordon, MF; Greene, PE; Rogers, JD	1
Galiano, ML; Grandas, F	1
Hobson, DE; Martin, WR; Pourcher, E	1
Arnold, G; Kupsch, A	1
Phillips, P	1
Weiner, WJ	1
Montastruc, JL; Rascol, O; Senard, JM	1
Lam, YW	1
Abramova, NN; Bennett, JP; Cassarino, DS; Halvorsen, EM; Parker, WD; Sturgill, TW; Swerdlow, RH	1
Olanow, CW; Roth, T; Schapira, AH	1
Groenke, L; Mueller, D; Oechsner, M	1
Ryan, M; Slevin, JT; Wells, A	1
Clarke C, E; Clarke J, A; Speller J, M	1
Fahn, S; Frucht, SJ; Greene, PE	1
Anderson, WM; Gauger, L; Hauser, RA; Zesiewicz, TA	1
Shuster, J	1
Cassel, W; Krüger, HP; Möller, JC; Oertel, WH; Peter, JH; Stiasny, K	1
Blasucci, L; Goetz, CG; Kujawa, K; Leurgans, S; Raman, R	1
Tanner, CM	1
de Yebenes, JG	1
Hubble, JP	1
Hauser, RA; McDowell Anderson, W; Wahba, MN; Zesiewicz, TA	1
Appel, SH; Jankovic, J; Le, WD; Xie, W	1
Hebenstreit, E; Pinter, MM; Rutgers, AW	1
Earl-Slater, A; Walley, T	1
Sternon, J; Supiot, F; Zegers de Beyl, D	1
Hanna, PA; Jankovic, J; Ondo, WG; Ratkos, L	1
Agapito, C; Bhattacharya, KF; Chaudhuri, KR; Pal, S	1
Moller, H	1
Guttman, M; Houle, S; Hussey, D; Kish, S; Stewart, D; Wilson, A	1
Jankovic, J; Le, WD	1
Ball, J	1
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A	1
Etminan, M; Rochon, PA; Samii, A; Takkouche, B	1
Biglan, KM; Holloway, RG	1
Abramova, NA; Bennett, JP; Cassarino, DS; Khan, SM; Painter, TW	1
Di Rocco, A; Tabamo, RE	1
Adler, CH; Blasucci, L; Carvey, P; Caviness, JN; Chase, WM; Ferry, JJ; Goetz, CG; Kompoliti, K; Leibowitz, MT; Leurgans, S; Pincus, JH; Raman, R; Tan, E; Yones, LC	1
Gasser, T; Meier, D; Oertel, WH; Pogarell, O; Pollentier, S; Spieker, S; van Hilten, JJ	1

Reviews

86 review(s) available for pramipexole and Idiopathic Parkinson Disease

Article	Year
Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson disease: A systematic review and meta-analysis. Medicine, 2021, Nov-05, Volume: 100, Issue:44 Topics: Antiparkinson Agents; Combined Modality Therapy; Humans; Levodopa; Multicenter Studies as Topic; Parkinson Disease; Pramipexole; Treatment Outcome	2021
P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson's Disease. Advances in therapy, 2022, Volume: 39, Issue:5 Topics: Humans; Indans; Levodopa; Parkinson Disease; Pramipexole	2022
Efficacy of pramipexole on quality of life in patients with Parkinson's disease: a systematic review and meta-analysis. BMC neurology, 2022, Aug-25, Volume: 22, Issue:1 Topics: Antiparkinson Agents; Humans; Parkinson Disease; Pramipexole; Quality of Life; Severity of Illness Index	2022
Efficacy and safety of non-ergot dopamine-receptor agonists as an adjunct to levodopa in advanced Parkinson's disease: A network meta-analysis. European journal of neurology, 2023, Volume: 30, Issue:3 Topics: Antiparkinson Agents; Dopamine; Dopamine Agonists; Humans; Levodopa; Network Meta-Analysis; Parkinson Disease; Pramipexole	2023
Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis. European journal of pharmacology, 2023, Sep-05, Volume: 954 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Levodopa; Network Meta-Analysis; Parkinson Disease; Pergolide; Pramipexole	2023
Classics in Chemical Neuroscience: Pramipexole. ACS chemical neuroscience, 2020, 09-02, Volume: 11, Issue:17 Topics: Benzothiazoles; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Tremor	2020
Comparison of pramipexole and levodopa/benserazide combination therapy versus levodopa/benserazide monotherapy in the treatment of Parkinson's disease: a systematic review and meta-analysis. Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:9 Topics: Antiparkinson Agents; Benserazide; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Treatment Outcome	2021
The role of pramipexole in the treatment of patients with depression and Parkinson's disease: A meta-analysis of randomized controlled trials. Asian journal of psychiatry, 2021, Volume: 61 Topics: Depression; Humans; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Treatment Outcome	2021
Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson's Disease: A Network Meta-Analysis. Scientific reports, 2017, 04-04, Volume: 8 Topics: Bromocriptine; Cluster Analysis; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Network Meta-Analysis; Parkinson Disease; Picolinic Acids; Pramipexole; Selegiline; Tetrahydronaphthalenes; Thiophenes	2017
Efficacy and safety of pramipexole extended-release in Parkinson's disease: a review based on meta-analysis of randomized controlled trials. European journal of neurology, 2017, Volume: 24, Issue:6 Topics: Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Humans; Mental Status and Dementia Tests; Parkinson Disease; Pramipexole; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome	2017
Hiccups in Parkinson's disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature. European journal of clinical pharmacology, 2017, Volume: 73, Issue:9 Topics: Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Female; Hiccup; Humans; Male; Middle Aged; Parkinson Disease; Pharmacovigilance; Pramipexole; Tetrahydronaphthalenes; Thiophenes	2017
Meta-analysis of the adverse events associated with extended-release versus standard immediate-release pramipexole in Parkinson disease. Medicine, 2018, Volume: 97, Issue:34 Topics: Benzothiazoles; Delayed-Action Preparations; Dopamine Agonists; Drug Administration Schedule; Female; Humans; Male; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index	2018
Hypotension and bradycardia, a serious adverse effect of piribedil, a case report and literature review. BMC neurology, 2018, Dec-27, Volume: 18, Issue:1 Topics: Bradycardia; Dopamine; Dopamine Agonists; Humans; Hypotension; Male; Middle Aged; Parkinson Disease; Piribedil; Pramipexole	2018
Indirect Comparison of Ropinirole and Pramipexole as Levodopa Adjunctive Therapy in Advanced Parkinson's Disease: A Systematic Review and Network Meta-Analysis. Advances in therapy, 2019, Volume: 36, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Combined Modality Therapy; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole	2019
Rotigotine Transdermal Patch: A Review in Parkinson's Disease. CNS drugs, 2019, Volume: 33, Issue:7 Topics: Administration, Cutaneous; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Quality of Life; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch	2019
Anti-Parkinson's disease drugs and pharmacogenetic considerations. Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:7 Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline	2013
Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis. PloS one, 2013, Volume: 8, Issue:10 Topics: Antidepressive Agents, Tricyclic; Benzothiazoles; Depression; Humans; Odds Ratio; Parkinson Disease; Pergolide; Pramipexole; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2013
Meta-analysis of the efficacy and safety of long-acting non-ergot dopamine agonists in Parkinson's disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2014, Volume: 21, Issue:7 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Drug Delivery Systems; Humans; Indoles; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Statistics, Nonparametric	2014
[Programs for continuing medical education: a session: 4. The pathogenesis and update for the treatments of Parkinson's disease]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2014, Mar-10, Volume: 103, Issue:3 Topics: Benserazide; Benzothiazoles; Catechols; Circadian Rhythm; Dementia; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Dyskinesias; Education, Medical, Continuing; Hallucinations; Humans; Levodopa; Nitriles; Parkinson Disease; Practice Guidelines as Topic; Pramipexole; Reference Standards; Referral and Consultation	2014
The benefits of pramipexole selection in the treatment of Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014, Volume: 35, Issue:10 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Drug Interactions; Humans; Parkinson Disease; Pramipexole; Treatment Outcome	2014
Pramipexole extended-release: a review of its use in patients with Parkinson's disease. Drugs, 2014, Volume: 74, Issue:18 Topics: Activities of Daily Living; Administration, Oral; Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Delayed-Action Preparations; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Motor Activity; Parkinson Disease; Patient Acuity; Pramipexole; Treatment Outcome	2014
[A current view on dopamine receptor agonists in the treatment of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:9 Topics: Antiparkinson Agents; Benzothiazoles; Controlled Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Humans; Levodopa; Parkinson Disease; Pramipexole; Quality of Life; Tremor	2015
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease? Translational psychiatry, 2016, Mar-08, Volume: 6 Topics: Anhedonia; Animals; Anxiety; Apathy; Behavior, Animal; Benzothiazoles; Depression; Disease Models, Animal; Dopamine Agonists; Mice; Neostriatum; Parkinson Disease; Pramipexole; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Substantia Nigra	2016
[Pathological gambling and Parkinson disease]. Brain and nerve = Shinkei kenkyu no shinpo, 2008, Volume: 60, Issue:9 Topics: Benzothiazoles; Deep Brain Stimulation; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D3; Risk	2008
The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies. Clinical therapeutics, 2009, Volume: 31, Issue:1 Topics: Affect; Aged; Antiparkinson Agents; Benzothiazoles; Female; Humans; Male; Middle Aged; Motivation; Odds Ratio; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Severity of Illness Index	2009
Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole. Current medical research and opinion, 2009, Volume: 25, Issue:12 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Cytoprotection; Dopamine Agonists; Humans; Models, Biological; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Signal Transduction	2009
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data. The Journal of neuropsychiatry and clinical neurosciences, 2010,Winter, Volume: 22, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid	2010
[Clinical data of the prolonged-release formulation of ropinirole]. Fortschritte der Neurologie-Psychiatrie, 2010, Volume: 78 Suppl 1 Topics: Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Quality of Life	2010
Pramipexole extended release: in Parkinson's disease. CNS drugs, 2010, Volume: 24, Issue:4 Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Delayed-Action Preparations; Humans; Parkinson Disease; Pramipexole; Treatment Outcome	2010
[Clinical studies on pramipexol retard]. Ideggyogyaszati szemle, 2010, May-30, Volume: 63, Issue:5-6 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Parkinson Disease; Pramipexole; Treatment Outcome	2010
Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:13 Topics: Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Humans; Male; Parkinson Disease; Pramipexole	2010
Role of pramipexole in the management of Parkinson's disease. CNS drugs, 2010, Volume: 24, Issue:10 Topics: Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Humans; Parkinson Disease; Pramipexole	2010
[Dopaminergic neuroprotection and reconstruction of neural network tiara]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2010, Volume: 130, Issue:10 Topics: Animals; Azepines; Benzothiazoles; Brain; Dopamine; Dopamine Agonists; Embryonic Stem Cells; Humans; Levodopa; Mice; Microglia; Nerve Net; Nerve Regeneration; Neuroprotective Agents; Parkinson Disease; Planarians; Pramipexole; Rats	2010
Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release. European journal of neurology, 2011, Volume: 18 Suppl 1 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase Inhibitors; Catechols; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dopamine Agonists; Drug Delivery Systems; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Nitriles; Parkinson Disease; Pramipexole	2011
Treatment of depressive symptoms in Parkinson's disease. European journal of neurology, 2011, Volume: 18 Suppl 1 Topics: Antidepressive Agents, Tricyclic; Antiparkinson Agents; Benzothiazoles; Depression; Desipramine; Dopamine Agonists; Humans; Levodopa; Nortriptyline; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2011
Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease. Physiology & behavior, 2011, Jul-25, Volume: 104, Issue:1 Topics: Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole	2011
Pramipexole for the treatment of early Parkinson's disease. Expert review of neurotherapeutics, 2011, Volume: 11, Issue:7 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Humans; Parkinson Disease; Pramipexole	2011
Pramipexole extended release in Parkinson's disease. Expert review of neurotherapeutics, 2011, Volume: 11, Issue:9 Topics: Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Drug Administration Schedule; Humans; Parkinson Disease; Pramipexole; Treatment Outcome	2011
Pharmacokinetic evaluation of pramipexole. Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:10 Topics: Benzothiazoles; Dopamine Agonists; Drug Delivery Systems; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Heart Valve Diseases; Humans; Levodopa; Parkinson Disease; Pharmacogenetics; Pramipexole; Receptors, Dopamine; Restless Legs Syndrome	2011
Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline. The International journal of neuroscience, 2012, Volume: 122, Issue:7 Topics: Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cross-Sectional Studies; Databases, Bibliographic; Fatigue; Female; Gastrointestinal Diseases; Humans; Indans; Indoles; Logistic Models; Male; Parkinson Disease; Patient Dropouts; Pramipexole; Sleep Wake Disorders; Treatment Outcome	2012
Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease. Clinical interventions in aging, 2012, Volume: 7 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Severity of Illness Index	2012
The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson s disease: a review of the literature. Current medicinal chemistry, 2002, Volume: 9, Issue:14 Topics: Antiparkinson Agents; Benzothiazoles; Cholinergic Antagonists; Dysarthria; Humans; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Speech; Speech Therapy; Thiazoles; Voice	2002
Two advances in the management of Parkinson disease. Cleveland Clinic journal of medicine, 2002, Volume: 69, Issue:8 Topics: Age Factors; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dyskinesias; Electric Stimulation Therapy; Forecasting; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Risk Factors; Stereotaxic Techniques; Thiazoles	2002
DA agonists -- non-ergot derivatives: pramipexole: management of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4 Topics: Benzothiazoles; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Pramipexole; Psychomotor Disorders; Randomized Controlled Trials as Topic; Thiazoles	2002
[Use of dopamine agonists in the treatment of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2002, Volume: 102, Issue:9 Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors	2002
Sleep attacks--facts and fiction: a critical review. Advances in neurology, 2003, Volume: 91 Topics: Antiparkinson Agents; Benzothiazoles; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles	2003
Dopamine agonists and neuroprotection in Parkinson's disease. European journal of neurology, 2002, Volume: 9 Suppl 3 Topics: Animals; Antioxidants; Benzothiazoles; Disease Models, Animal; Dopamine Agonists; Environmental Exposure; Humans; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Parkinsonian Disorders; Pramipexole; Thiazoles	2002
Do dopamine agonists or levodopa modify Parkinson's disease progression? European journal of neurology, 2002, Volume: 9 Suppl 3 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Dihydroxyphenylalanine; Disease Progression; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Indoles; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes	2002
Dopamine agonist monotherapy in Parkinson's disease. Lancet (London, England), 2002, Nov-30, Volume: 360, Issue:9347 Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2002
Neuroprotection in idiopathic Parkinson's disease. Journal of neurology, 2002, Volume: 249 Suppl 3 Topics: Antiparkinson Agents; Benzothiazoles; Cell Death; Dopamine Agonists; Humans; Indoles; Levodopa; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2002
Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson's disease: a meta-analysis. Drug safety, 2003, Volume: 26, Issue:6 Topics: Adverse Drug Reaction Reporting Systems; Benzothiazoles; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Risk Assessment; Thiazoles	2003
Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison. Drugs & aging, 2003, Volume: 20, Issue:11 Topics: Age of Onset; Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Evidence-Based Medicine; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2003
Clinical strategies to prevent and delay motor complications. Neurology, 2003, Sep-23, Volume: 61, Issue:6 Suppl 3 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2003
[Pharmacological profiles and clinical effects of antiparkinsonian agent, pramipexole]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2004, Volume: 123, Issue:6 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles	2004
Sleep attacks in patients receiving dopamine-receptor agonists. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Mar-01, Volume: 62, Issue:5 Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide; Pramipexole; Restless Legs Syndrome; Thiazoles	2005
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone	2005
Pramipexole in the treatment of Parkinson's disease: new developments. Expert review of neurotherapeutics, 2005, Volume: 5, Issue:5 Topics: Antiparkinson Agents; Benzothiazoles; Depression; Expert Testimony; Humans; Parkinson Disease; Pramipexole; Product Surveillance, Postmarketing; Thiazoles; Tremor	2005
Present and future drug treatment for Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:11 Topics: Benzothiazoles; Corpus Striatum; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Indans; Indoles; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Psychomotor Performance; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Substantia Nigra; Thiazoles; Urinary Incontinence	2005
[Treatment of Parkinson disease: therapeutic reserve of the dopaminergic agonist]. Neurologia (Barcelona, Spain), 2006, Volume: 21, Issue:7 Topics: Benzothiazoles; Cabergoline; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Humans; Parkinson Disease; Pramipexole	2006
Pramipexole in psychiatry: a systematic review of the literature. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:8 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Bipolar Disorder; Compulsive Behavior; Depressive Disorder; Dopamine Agonists; Drug Interactions; Drug Resistance; Headache; Humans; Nausea; Parkinson Disease; Pramipexole; Psychoses, Substance-Induced; Sleep Wake Disorders	2007
Rapid eye movement sleep behavior disorder. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:11 Topics: Anticonvulsants; Antiparkinson Agents; Benzothiazoles; Clonazepam; Comorbidity; Dopamine Agonists; GABA Modulators; Humans; Melatonin; Parkinson Disease; Pramipexole; REM Sleep Behavior Disorder	2007
Second generation of dopamine agonists: pros and cons. Journal of neural transmission. Supplementum, 1995, Volume: 45 Topics: Antiparkinson Agents; Benzothiazoles; Cabergoline; Dopamine Agonists; Drugs, Investigational; Ergolines; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles	1995
New pharmacotherapy for Parkinson's disease. The Annals of pharmacotherapy, 1997, Volume: 31, Issue:10 Topics: Benzophenones; Benzothiazoles; Cabergoline; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Enzyme Inhibitors; Ergolines; Humans; Indoles; Nitriles; Nitrophenols; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Thiazoles; Tolcapone	1997
New options for treatment of Parkinson's disease. Bailliere's clinical neurology, 1997, Volume: 6, Issue:1 Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Cabergoline; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Enzyme Inhibitors; Ergolines; Guidelines as Topic; Humans; Indoles; Nitriles; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone; Treatment Outcome	1997
Pramipexole. A review of its use in the management of early and advanced Parkinson's disease. Drugs & aging, 1998, Volume: 12, Issue:6 Topics: Antiparkinson Agents; Benzothiazoles; Disease Progression; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles; Treatment Outcome	1998
Do dopamine agonists provide neuroprotection? Neurology, 1998, Volume: 51, Issue:2 Suppl 2 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles	1998
Clinical pharmacology of dopamine agonists in Parkinson's disease. Drugs & aging, 1998, Volume: 13, Issue:5 Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Ergot Alkaloids; Humans; Indoles; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles	1998
Dopamine agonists. The Medical clinics of North America, 1999, Volume: 83, Issue:2 Topics: Apomorphine; Benzothiazoles; Bromocriptine; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Receptors, Dopamine; Thiazoles; Treatment Outcome	1999
D-3 receptor agonists: combined action neurologic and neuropsychiatric agents. Journal of the neurological sciences, 1999, Feb-01, Volume: 163, Issue:1 Topics: Animals; Benzothiazoles; Dopamine Agonists; Humans; Mental Disorders; Nervous System Diseases; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles	1999
Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease. Journal of the neurological sciences, 1999, Feb-01, Volume: 163, Issue:1 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Levodopa; Motor Activity; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles	1999
[Pramipexol: a new dopaminergic agonist for the treatment of Parkinson disease]. Neurologia (Barcelona, Spain), 1999, Volume: 14, Issue:5 Topics: Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome	1999
Ropinirole and pramipexole, the new agonists. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1999, Volume: 26 Suppl 2 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Binding, Competitive; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Receptors, Dopamine; Thiazoles	1999
The initial treatment of Parkinson's disease should begin with levodopa. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors	1999
Treatment of Parkinson's disease should begin with a dopamine agonist. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles	1999
Clinical pharmacology of dopamine agonists. Pharmacotherapy, 2000, Volume: 20, Issue:1 Pt 2 Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Drug Interactions; Ergolines; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles	2000
New drugs for the treatment of Parkinson's disease. Pharmacotherapy, 2000, Volume: 20, Issue:1 Pt 2 Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Cabergoline; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Drug Synergism; Enzyme Inhibitors; Ergolines; Humans; Indoles; Levodopa; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone	2000
Waking up to sleep episodes in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:2 Topics: Antiparkinson Agents; Automobile Driving; Benzothiazoles; Dopamine Agents; Humans; Indoles; Narcolepsy; Parkinson Disease; Pramipexole; Risk Factors; Thiazoles	2000
Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles	2000
["Sleep attacks" in Parkinson patients. A side effect of nonergoline dopamine agonists or a class effect of dopamine agonists?]. Der Nervenarzt, 2000, Volume: 71, Issue:8 Topics: Accidents, Traffic; Automobile Driving; Benzothiazoles; Contraindications; Dopamine Agents; Dopamine Agonists; Germany; Humans; Indoles; Legislation, Drug; Levodopa; Narcolepsy; Parkinson Disease; Pramipexole; Thiazoles	2000
Introduction: pramipexole: a novel dopamine agonist for the treatment of Parkinson's disease. European journal of neurology, 2000, Volume: 7 Suppl 1 Topics: Benzothiazoles; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles	2000
Pre-clinical studies of pramipexole: clinical relevance. European journal of neurology, 2000, Volume: 7 Suppl 1 Topics: Animals; Benzothiazoles; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles	2000
Pramipexole in the treatment of advanced Parkinson's disease. European journal of neurology, 2000, Volume: 7 Suppl 1 Topics: Benzothiazoles; Clinical Trials, Phase III as Topic; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles	2000
Digest of evidence ... pramipexole and Parkinson's disease. Clinical performance and quality health care, 2000, Volume: 8, Issue:4 Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Evidence-Based Medicine; Humans; Parkinson Disease; Pramipexole; Thiazoles; United Kingdom	2000
Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs & aging, 2001, Volume: 18, Issue:6 Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Bromocriptine; Cell Culture Techniques; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Models, Animal; Neuroprotective Agents; Parkinson Disease; Pergolide; Pramipexole; Substantia Nigra; Thiazoles	2001
Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials. Drug safety, 2001, Volume: 24, Issue:11 Topics: Antiparkinson Agents; Benzothiazoles; Disorders of Excessive Somnolence; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; MEDLINE; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Risk Factors; Thiazoles	2001
A review of pramipexole and its clinical utility in Parkinson's disease. Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:2 Topics: Animals; Benzothiazoles; Dopamine Agonists; Humans; Hypotension, Orthostatic; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Sleep Wake Disorders; Thiazoles; Treatment Outcome	2002

Trials

84 trial(s) available for pramipexole and Idiopathic Parkinson Disease

Article	Year
Comparison of pramipexole versus ropinirole in the treatment of Parkinson's disease. Ideggyogyaszati szemle, 2022, 01-30, Volume: 75, Issue:1-02 Topics: Adult; Aged; Aged, 80 and over; Humans; Indoles; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Pramipexole	2022
Zishen pingchan granules combined with pramipexole in the improvement of depressive symptoms in Parkinson's disease: a prospective, multicenter, randomized, double-blind, controlled clinical study. Journal of translational medicine, 2022, 08-12, Volume: 20, Issue:1 Topics: Aged; Benzothiazoles; Depression; Double-Blind Method; Humans; Parkinson Disease; Pramipexole; Prospective Studies; Quality of Life; Severity of Illness Index; Treatment Outcome	2022
Efficacy of pramipexole combined with levodopa for Parkinson's disease treatment and their effects on QOL and serum TNF- The Journal of international medical research, 2020, Volume: 48, Issue:7 Topics: Antiparkinson Agents; Benzothiazoles; Humans; Levodopa; Parkinson Disease; Pramipexole; Quality of Life; Tumor Necrosis Factor-alpha	2020
A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Indans; Israel; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pramipexole; Severity of Illness Index; Triethylenemelamine; United States	2017
Comparison of nocturnal symptoms in advanced Parkinson's disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations. Drug design, development and therapy, 2018, Volume: 12 Topics: Antiparkinson Agents; Double-Blind Method; Drug Compounding; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Parkinson Disease; Pramipexole; Sleep; Sleep Wake Disorders; Software	2018
Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial. Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Combinations; Drug Substitution; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole	2019
Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial. The Lancet. Neurology, 2013, Volume: 12, Issue:8 Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Quality of Life; Retrospective Studies; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon	2013
Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson's disease: results from an open-label study. Drug research, 2013, Volume: 63, Issue:12 Topics: Antiparkinson Agents; Benzothiazoles; Caregivers; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Parkinson Disease; Patient Preference; Pramipexole; Quality of Life; Surveys and Questionnaires; Treatment Outcome	2013
Comparison of once-daily versus twice-daily combination of ropinirole prolonged release in Parkinson's disease. BMC neurology, 2013, Sep-02, Volume: 13 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Indoles; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Retrospective Studies; Surveys and Questionnaires	2013
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease. European journal of neurology, 2014, Volume: 21, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Severity of Illness Index; Time Factors	2014
Switch from oral pramipexole or ropinirole to rotigotine transdermal system in advanced Parkinson's disease: an open-label study. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:7 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Drug Substitution; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Tetrahydronaphthalenes; Thiophenes	2015
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study. BMC neurology, 2015, Feb-28, Volume: 15 Topics: Activities of Daily Living; Administration, Cutaneous; Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes	2015
Rhythmic auditory stimulation with visual stimuli on motor and balance function of patients with Parkinson's disease. European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:11 Topics: Acoustic Stimulation; Aged; Benserazide; Benzothiazoles; Catechols; Dose-Response Relationship, Drug; Drug Combinations; Female; Gait; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Periodicity; Piribedil; Postural Balance; Pramipexole; Walking	2015
[Pain and depression in Parkinson's disease: new therapeutic possibilities of pramipexole]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:11 Topics: Aged; Amantadine; Benzothiazoles; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Movement Disorders; Pain; Pain Measurement; Parkinson Disease; Pramipexole; Severity of Illness Index	2008
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects. British journal of clinical pharmacology, 2009, Volume: 67, Issue:3 Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cross-Over Studies; Double-Blind Method; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Pramipexole; Sleep Wake Disorders; Treatment Outcome; Young Adult	2009
Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:6 Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Humans; Japan; Outcome Assessment, Health Care; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Treatment Outcome	2009
Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory. Neuropsychologia, 2009, Volume: 47, Issue:5 Topics: Attention; Benzothiazoles; Cognition; Dopamine Agonists; Female; Humans; Male; Memory; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pergolide; Pramipexole; Reaction Time; Severity of Illness Index; Task Performance and Analysis	2009
Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Archives of neurology, 2009, Volume: 66, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cohort Studies; Disability Evaluation; Disease Progression; Early Diagnosis; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Quality of Life; Time; Treatment Outcome	2009
Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease? Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:13 Topics: Benzothiazoles; Dopamine Agonists; Frontal Lobe; Gambling; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Pramipexole; Psychomotor Performance; Reward; Risk-Taking	2009
An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Oct-30, Volume: 24, Issue:14 Topics: Accidental Falls; Aged; Antiparkinson Agents; Benzothiazoles; Cohort Studies; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Patient Satisfaction; Pramipexole	2009
Effects of a dopamine agonist on the pharmacodynamics of levodopa in Parkinson disease. Archives of neurology, 2010, Volume: 67, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Brain; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Risk Assessment; Treatment Outcome	2010
[Effect of dopamine agonist pramipexole (mirapex) on tremor, affective disorders and quality of life in patients with Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:2 Topics: Adult; Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Pramipexole; Quality of Life; Tremor	2010
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology, 2010, Volume: 9, Issue:6 Topics: Aged; Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Depressive Disorder; Dopamine Agonists; Double-Blind Method; Dyskinesias; Europe; Female; Humans; Male; Parkinson Disease; Pramipexole; Psychiatric Status Rating Scales; Severity of Illness Index; South Africa; Time Factors; Treatment Outcome	2010
Rationale for delayed-start study of pramipexole in Parkinson's disease: the PROUD study. Movement disorders : official journal of the Movement Disorder Society, 2010, Aug-15, Volume: 25, Issue:11 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Pain Measurement; Parkinson Disease; Pramipexole; Quality of Life; Severity of Illness Index	2010
Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2010, Oct-30, Volume: 25, Issue:14 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Severity of Illness Index; Time Factors	2010
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2010, Nov-15, Volume: 25, Issue:15 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Satisfaction; Pramipexole; Quality of Life; Severity of Illness Index; Treatment Outcome	2010
Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial. Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:1 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome	2011
Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease. European journal of neurology, 2011, Volume: 18, Issue:11 Topics: Aged; Benzothiazoles; Comorbidity; Disorders of Excessive Somnolence; Dopamine Agonists; Female; Humans; Indoles; Kidney Diseases; Male; Middle Aged; Parkinson Disease; Pramipexole	2011
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial. Neurology, 2011, Aug-23, Volume: 77, Issue:8 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Pramipexole; Severity of Illness Index; Time Factors; Treatment Outcome	2011
Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial. Neurology, 2011, Aug-23, Volume: 77, Issue:8 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome	2011
Temporal stability of the Unified Dyskinesia Rating Scale. Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:14 Topics: Aged; Benzothiazoles; Benzoxazoles; Disability Evaluation; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Neurologic Examination; Observer Variation; Parkinson Disease; Piperazines; Pramipexole; Reproducibility of Results; Videotape Recording	2011
Pramipexole reduces the prevalence of fatigue in patients with Parkinson's disease. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:19 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cross-Sectional Studies; Fatigue; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole	2011
Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson's disease. Pharmacological reports : PR, 2011, Volume: 63, Issue:4 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Drug Combinations; Female; Flow Cytometry; Gene Expression Regulation; Humans; Indoles; Levodopa; Lymphocytes; Male; Middle Aged; Parkinson Disease; Pramipexole	2011
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. European journal of neurology, 2013, Volume: 20, Issue:1 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Administration Schedule; Female; Humans; International Cooperation; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Pramipexole; Self Report; Time Factors; Treatment Outcome	2013
The role of the dopaminergic system in mood, motivation and cognition in Parkinson's disease: a double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate. Journal of the neurological sciences, 2012, Sep-15, Volume: 320, Issue:1-2 Topics: Affect; Aged; Benzothiazoles; Cognition; Dopamine Agonists; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Double-Blind Method; Female; Humans; Male; Methylphenidate; Middle Aged; Motivation; Parkinson Disease; Pramipexole; Psychiatric Status Rating Scales; Psychomotor Performance; Reaction Time	2012
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. European journal of neurology, 2013, Volume: 20, Issue:1 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Drug Substitution; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Severity of Illness Index; Time Factors; Treatment Outcome	2013
Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson's disease. Current medical research and opinion, 2013, Volume: 29, Issue:1 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Indans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Time Factors	2013
Caffeine consumption and risk of dyskinesia in CALM-PD. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:3 Topics: Adenosine A2 Receptor Antagonists; Aged; Antiparkinson Agents; Benzothiazoles; Caffeine; Cohort Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Proportional Hazards Models; Retrospective Studies; Risk	2013
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:3 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3	2013
Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:2 Topics: Aged; Aged, 80 and over; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Surveys and Questionnaires; Thiazoles; Tremor	2003
Combination of two different dopamine agonists in the management of Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23 Suppl 2 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome	2002
Pramipexole in comparison to l-dopa: a neuropsychological study. Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:4 Topics: Aged; Analysis of Variance; Benzothiazoles; Cognition Disorders; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Thiazoles	2003
Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. European journal of neurology, 2003, Volume: 10, Issue:4 Topics: Activities of Daily Living; Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Depression; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Pergolide; Placebos; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Single-Blind Method; Thiazoles; Treatment Outcome	2003
Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison. Drugs & aging, 2003, Volume: 20, Issue:11 Topics: Age of Onset; Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Evidence-Based Medicine; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2003
Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:10 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Demography; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Quality of Life; Thiazoles; Time Factors; Treatment Outcome	2003
Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease. Journal of the neurological sciences, 2003, Dec-15, Volume: 216, Issue:1 Topics: Adult; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Female; Hong Kong; Humans; Levodopa; Male; Parkinson Disease; Pramipexole; Software Design; Taiwan; Thiazoles; Treatment Outcome	2003
Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on Parkinsonian tremor. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:11 Topics: Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Thiazoles; Tremor	2003
Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:1 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Double-Blind Method; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Pain Measurement; Parkinson Disease; Pramipexole; Quality of Life; Thiazoles	2004
[A comparative study of efficacy of dopamine receptors agonists and catechol-O-methyltransferase in the treatment of late stages of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2004, Volume: 104, Issue:1 Topics: Activities of Daily Living; Benzophenones; Benzothiazoles; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Nitriles; Nitrophenols; Parkinson Disease; Pergolide; Pramipexole; Quality of Life; Thiazoles; Tolcapone; Treatment Outcome	2004
Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease. Journal of neurology, 2004, Volume: 251, Issue:3 Topics: Aged; Analysis of Variance; Benzothiazoles; Dopamine Agonists; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles	2004
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Archives of neurology, 2004, Volume: 61, Issue:7 Topics: Aged; Benzothiazoles; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Proportional Hazards Models; Quality of Life; Severity of Illness Index; Thiazoles	2004
Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:10 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pilot Projects; Pramipexole; Thiazoles	2004
A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide. European journal of neurology, 2005, Volume: 12, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Thiazoles; Tremor	2005
Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Demography; Depression; Disorders of Excessive Somnolence; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Parkinson Disease; Pramipexole; Severity of Illness Index; Thiazoles; Tremor	2005
Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole. The Journal of neuropsychiatry and clinical neurosciences, 2005,Spring, Volume: 17, Issue:2 Topics: Activities of Daily Living; Aged; Aging; Antiparkinson Agents; Benzothiazoles; Depression; Dose-Response Relationship, Drug; Female; Humans; Male; Parkinson Disease; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Performance; Thiazoles	2005
Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness. PharmacoEconomics, 2005, Volume: 23, Issue:12 Topics: Administration, Oral; Adult; Antiparkinson Agents; Benzothiazoles; Cost-Benefit Analysis; Double-Blind Method; Female; Health Expenditures; Humans; Levodopa; Male; Parkinson Disease; Pramipexole; Prospective Studies; Reproducibility of Results; Sex Factors; Thiazoles; Time Factors; Treatment Outcome	2005
Motor deficits in Parkinsonian reaching: dopa-sensitivity influenced by real-world task constraint. Journal of motor behavior, 2006, Volume: 38, Issue:1 Topics: Activities of Daily Living; Aged; Amantadine; Antiparkinson Agents; Arm; Benzothiazoles; Biomechanical Phenomena; Carbidopa; Catechols; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Movement; Nitriles; Parkinson Disease; Pramipexole; Thiazoles	2006
Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study. Journal of neurology, 2006, Volume: 253, Issue:5 Topics: Aged; Analysis of Variance; Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Psychiatric Status Rating Scales; Sertraline; Single-Blind Method	2006
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease. Journal of the neurological sciences, 2006, Oct-25, Volume: 248, Issue:1-2 Topics: Aged; Benzothiazoles; Chi-Square Distribution; Depression; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Mood Disorders; Movement Disorders; Parkinson Disease; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index	2006
Increase in body weight after pramipexole treatment in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11 Topics: Affect; Aged; Antiparkinson Agents; Benzothiazoles; Body Mass Index; Body Weight; Female; Follow-Up Studies; Humans; Male; Middle Aged; Movement; Parkinson Disease; Pramipexole; Severity of Illness Index	2006
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study. Movement disorders : official journal of the Movement Disorder Society, 2007, Jan-15, Volume: 22, Issue:2 Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Hypertrophy, Left Ventricular; Indoles; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Tricuspid Valve Insufficiency	2007
Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease. Archives of neurology, 2006, Volume: 63, Issue:12 Topics: Age of Onset; Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Dyskinesias; Female; Humans; Levodopa; Logistic Models; Male; Middle Aged; Parkinson Disease; Pramipexole; Proportional Hazards Models; Prospective Studies; Retrospective Studies	2006
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease. Journal of neurology, 2006, Volume: 253, Issue:12 Topics: Benzothiazoles; Dopamine Agonists; Double-Blind Method; Endpoint Determination; Female; Humans; Indoles; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pramipexole; Severity of Illness Index; Time Factors	2006
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. The Lancet. Neurology, 2007, Volume: 6, Issue:6 Topics: Administration, Cutaneous; Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pramipexole; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome	2007
Impact of pramipexole on the onset of levodopa-related dyskinesias. Movement disorders : official journal of the Movement Disorder Society, 2007, Jul-15, Volume: 22, Issue:9 Topics: Aged; Akathisia, Drug-Induced; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Probability	2007
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology, 2007, Jul-10, Volume: 69, Issue:2 Topics: Adult; Age Distribution; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cohort Studies; Comorbidity; Disorders of Excessive Somnolence; Double-Blind Method; Edema; Female; Hallucinations; Heart Diseases; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Risk Factors; Sex Distribution	2007
Use of the dopamine receptor agonist Mirapex in the treatment of Parkinson's disease. Neuroscience and behavioral physiology, 2007, Volume: 37, Issue:6 Topics: Activities of Daily Living; Aged; Anxiety; Benzothiazoles; Depression; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Review Literature as Topic; Time Factors	2007
Pramipexole in patients with early Parkinson's disease. Clinical neuropharmacology, 1995, Volume: 18, Issue:4 Topics: Adult; Benzothiazoles; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Thiazoles; Time Factors	1995
The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease. Journal of neural transmission. Supplementum, 1995, Volume: 45 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Single-Blind Method; Thiazoles	1995
Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. Parkinson Study Group. JAMA, 1997, Jul-09, Volume: 278, Issue:2 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Models, Statistical; Parkinson Disease; Pramipexole; Severity of Illness Index; Thiazoles	1997
Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study. Neurology, 1997, Volume: 49, Issue:1 Topics: Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Prognosis; Thiazoles	1997
Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group. Neurology, 1997, Volume: 49, Issue:3 Topics: Activities of Daily Living; Antiparkinson Agents; Benzothiazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Physical Examination; Placebos; Pramipexole; Severity of Illness Index; Thiazoles	1997
Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group. Neurology, 1997, Volume: 49, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pramipexole; Quality of Life; Severity of Illness Index; Thiazoles; Treatment Outcome	1997
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study. Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 66, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles	1999
Switching dopamine agonists in advanced Parkinson's disease: is rapid titration preferable to slow? Neurology, 1999, Apr-12, Volume: 52, Issue:6 Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Thiazoles; Titrimetry	1999
[Pramipexol: a new dopaminergic agonist for the treatment of Parkinson disease]. Neurologia (Barcelona, Spain), 1999, Volume: 14, Issue:5 Topics: Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome	1999
Pramipexole-induced somnolence and episodes of daytime sleep. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:4 Topics: Aged; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Narcolepsy; Parkinson Disease; Polysomnography; Pramipexole; Retrospective Studies; Thiazoles	2000
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. JAMA, 2000, Oct-18, Volume: 284, Issue:15 Topics: Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Dyskinesias; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Proportional Hazards Models; Quality of Life; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed, Single-Photon	2000
An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:11 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome	2000
Switching from pergolide to pramipexole in patients with Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:1 Topics: Accidental Falls; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Edema; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Pramipexole; Prospective Studies; Receptors, Dopamine; Sweating; Thiazoles; Treatment Outcome	2001
Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. Neurology, 2001, Jun-12, Volume: 56, Issue:11 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Receptors, Dopamine; Thiazoles; Tomography, Emission-Computed	2001
Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA, 2002, Apr-03, Volume: 287, Issue:13 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Brain; Cocaine; Disease Progression; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Degeneration; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Regression Analysis; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology, 2002, May-14, Volume: 58, Issue:9 Topics: Aged; Antiparkinson Agents; Area Under Curve; Benzothiazoles; Biological Availability; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Humans; Levodopa; Male; Parkinson Disease; Postmenopause; Pramipexole; Sex Factors; Thiazoles	2002
Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study. Journal of neurology, neurosurgery, and psychiatry, 2002, Volume: 72, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Drug Resistance; Electromyography; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pramipexole; Thiazoles; Treatment Outcome; Tremor	2002

Other Studies

219 other study(ies) available for pramipexole and Idiopathic Parkinson Disease

Article	Year
Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists. Bioorganic & medicinal chemistry, 2016, 06-15, Volume: 24, Issue:12 Topics: Adrenergic beta-2 Receptor Agonists; Animals; Benzoxazines; CHO Cells; Cricetulus; Dopamine Agonists; Drug Discovery; HEK293 Cells; Humans; Models, Molecular; Parkinson Disease; Polypharmacology; Receptors, Adrenergic, beta-2; Receptors, Dopamine D2	2016
Pramipexole regulates depression-like behavior via dopamine D3 receptor in a mouse model of Parkinson's disease. Brain research bulletin, 2021, Volume: 177 Topics: Animals; Benzothiazoles; Depression; Dopamine Agonists; Humans; Mice; Mice, Knockout; Parkinson Disease; Pramipexole; Quality of Life; Receptors, Dopamine D3	2021
Impulse control disorders associated with dopaminergic drugs: A disproportionality analysis using vigibase. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2022, Volume: 58 Topics: Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Humans; Parkinson Disease; Pramipexole	2022
Pramipexole Inhibits Neuronal Apoptosis in Rats with Parkinson's Disease. Journal of healthcare engineering, 2022, Volume: 2022 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain-Derived Neurotrophic Factor; MicroRNAs; Parkinson Disease; Pramipexole; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley	2022
Effects of Pramipexole Combined with Nerve Growth Factor on Cognitive Impairment and Urinary AD7c-NTP Expression in Patients with Parkinson's Disease. Computational and mathematical methods in medicine, 2022, Volume: 2022 Topics: Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Humans; Interleukin-6; Nerve Growth Factor; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Serotonin; Tumor Necrosis Factor-alpha	2022
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease. Acta pharmacologica Sinica, 2023, Volume: 44, Issue:1 Topics: Animals; Astrocytes; Autophagy; Inflammasomes; Lipopolysaccharides; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Parkinson Disease; Pramipexole	2023
D2/D3 Receptor Agonism: Paving the Way for a New Therapeutic Target for Taste Disorders in Parkinson's Disease and Other Conditions? The international journal of neuropsychopharmacology, 2022, 11-17, Volume: 25, Issue:11 Topics: Aged; Benzothiazoles; COVID-19; Dopamine; Dopamine Agonists; Healthy Volunteers; Humans; Parkinson Disease; Post-Acute COVID-19 Syndrome; Pramipexole; Quality of Life; Receptors, Dopamine D3; Taste; Taste Disorders	2022
Screening for impulse control disorders in Parkinson's disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2023, Volume: 44, Issue:2 Topics: Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Parkinson Disease; Pramipexole; Prospective Studies; Risk Factors	2023
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson's disease patient with Parkin gene mutation: a case report. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2023, Volume: 44, Issue:8 Topics: Adult; Deep Brain Stimulation; Dyskinesias; Humans; Levodopa; Male; Mutation; Parkinson Disease; Pramipexole; Quality of Life; Subthalamic Nucleus; Treatment Outcome	2023
Formulation and characterization of pramipexole containing buccal films for using in Parkinson's disease. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2023, Aug-01, Volume: 187 Topics: Administration, Buccal; Aged; Drug Carriers; Drug Delivery Systems; Humans; Mouth Mucosa; Parkinson Disease; Pramipexole	2023
Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit. Brain : a journal of neurology, 2023, Dec-01, Volume: 146, Issue:12 Topics: alpha-Synuclein; Animals; Cognition; Dopamine; Dopaminergic Neurons; Hippocampus; Humans; Levodopa; Neurotransmitter Agents; Parkinson Disease; Parkinsonian Disorders; Pramipexole; Rats	2023
The therapeutic role of repetitive transcranial magnetic stimulation (rTMS) in parkinsonian visual hallucinations: Electrophysiological correlates. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2019, Volume: 69 Topics: Aged, 80 and over; Antiparkinson Agents; Electroencephalography; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Pramipexole; Transcranial Magnetic Stimulation	2019
The anterior caudate nucleus supports impulsive choices triggered by pramipexole. Movement disorders : official journal of the Movement Disorder Society, 2020, Volume: 35, Issue:2 Topics: Animals; Benzothiazoles; Dopamine Agonists; Haplorhini; Impulsive Behavior; Parkinson Disease; Parkinsonian Disorders; Pramipexole; Reward; Ventral Striatum	2020
What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study. PloS one, 2020, Volume: 15, Issue:1 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Iatrogenic Disease; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Selective Serotonin Reuptake Inhibitors	2020
Development of a Physiologically Based Pharmacokinetic Model for Prediction of Pramipexole Pharmacokinetics in Parkinson's Disease Patients With Renal Impairment. Journal of clinical pharmacology, 2020, Volume: 60, Issue:8 Topics: Administration, Oral; Adult; Aged; Area Under Curve; Computer Simulation; Female; Humans; Male; Middle Aged; Models, Biological; Organic Cation Transporter 2; Parkinson Disease; Pramipexole; Renal Elimination; Renal Insufficiency; Tissue Distribution; Young Adult	2020
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson's disease patients: an European multicentre survey. Journal of neural transmission (Vienna, Austria : 1996), 2020, Volume: 127, Issue:6 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Dopamine Agonists; Humans; Middle Aged; Parkinson Disease; Pramipexole; Retrospective Studies; Tetrahydronaphthalenes; Transdermal Patch	2020
Immunomodulatory effect and clinical outcome in Parkinson's disease patients on levodopa-pramipexole combo therapy: A two-year prospective study. Journal of neuroimmunology, 2020, 10-15, Volume: 347 Topics: Antiparkinson Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunologic Factors; Levodopa; Longitudinal Studies; Parkinson Disease; Pramipexole; Prospective Studies; Time Factors; Treatment Outcome	2020
Retinal Layers and Choroid Measurements in Parkinson's Disease With or Without Pramipexole Treatment. Movement disorders : official journal of the Movement Disorder Society, 2020, Volume: 35, Issue:12 Topics: Choroid; Humans; Parkinson Disease; Pramipexole; Retina; Tomography, Optical Coherence	2020
Dilemma in Parkinson's Treatment; Levodopa Monotherapy May be the Best Choice. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2020, Volume: 79 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Depression; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Middle Aged; Movement; Parkinson Disease; Pramipexole; Psychotic Disorders; Quality of Life	2020
Effect of pH on Iontophoretic Transport of Pramipexole Dihydrochloride across Human Epidermal Membrane. Pharmaceutical research, 2021, Volume: 38, Issue:4 Topics: Administration, Cutaneous; Adult; Aged; Dopamine Agonists; Electroosmosis; Epidermis; Female; Humans; Hydrogen-Ion Concentration; Iontophoresis; Medication Adherence; Middle Aged; Parkinson Disease; Pramipexole; Skin Absorption; Young Adult	2021
Pramipexole attenuates 6-OHDA-induced Parkinson's disease by mediating the Nurr1/NF-κB pathway. Molecular biology reports, 2021, Volume: 48, Issue:4 Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Disease Models, Animal; NF-kappa B; Nuclear Receptor Subfamily 4, Group A, Member 2; Oxidopamine; Parkinson Disease; Pramipexole; Rats; Signal Transduction	2021
Effect of Pramipexole on Inflammatory Response in Central Nervous System of Parkinson's Disease Rat Model. Archives of medical research, 2022, Volume: 53, Issue:1 Topics: Animals; Parkinson Disease; Pramipexole; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tumor Necrosis Factor-alpha	2022
Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease. PloS one, 2021, Volume: 16, Issue:7 Topics: Aged; Antiparkinson Agents; Cross-Sectional Studies; Dopamine Agonists; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Regression Analysis; Retrospective Studies; Sleep; Tetrahydronaphthalenes; Thiophenes	2021
[Stealing as an Impulse Control Disorder Associated with Pramipexole - A Case Report from Forensic Psychiatric Practice]. Psychiatrische Praxis, 2017, Volume: 44, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Expert Testimony; Female; Humans; Levodopa; Mental Competency; Middle Aged; Parkinson Disease; Pramipexole; Risk Factors; Theft	2017
Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's disease. Journal of psychopharmacology (Oxford, England), 2017, Volume: 31, Issue:10 Topics: alpha-Synuclein; Animals; Benzothiazoles; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Impulsive Behavior; Male; Nucleus Accumbens; Parkinson Disease; Pramipexole; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Glutamate; Up-Regulation	2017
Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report. Medicine, 2017, Volume: 96, Issue:28 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Complex Regional Pain Syndromes; Dystonia; Female; Foot; Hand; Humans; Parkinson Disease; Pramipexole; Prednisolone	2017
Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity. International journal of biological macromolecules, 2018, Apr-01, Volume: 109 Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Benzothiazoles; Biomarkers; Blood-Brain Barrier; Chitosan; Disease Models, Animal; Dopamine; Drug Carriers; Drug Delivery Systems; Locomotion; Male; Nanoparticles; Parkinson Disease; Particle Size; Pramipexole; Rats; Reactive Oxygen Species; Tissue Distribution	2018
Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants. Parkinsonism & related disorders, 2018, Volume: 49 Topics: Adult; Age of Onset; Aged; Behavior, Addictive; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Pramipexole; Receptors, Dopamine D3	2018
Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study. Neuroreport, 2018, 05-02, Volume: 29, Issue:7 Topics: Aged; Antiparkinson Agents; Brain Mapping; Corpus Striatum; Dopamine; Dopamine Agonists; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Pramipexole; Punishment; Reward	2018
Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase. Neuropharmacology, 2018, Volume: 135 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; bcl-Associated Death Protein; Brain; Fingolimod Hydrochloride; Male; Mice; MPTP Poisoning; Neuroprotection; Parkinson Disease; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Pramipexole; Proto-Oncogene Proteins c-akt; Rotarod Performance Test; Tyrosine 3-Monooxygenase	2018
[Severe leg edema associated with the use of dopaminergic drugs in Parkinson's disease. Report of one case]. Revista medica de Chile, 2017, Volume: 145, Issue:12 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Edema; Humans; Leg; Levodopa; Male; Parkinson Disease; Pramipexole	2017
CircSNCA downregulation by pramipexole treatment mediates cell apoptosis and autophagy in Parkinson's disease by targeting miR-7. Aging, 2018, Jun-28, Volume: 10, Issue:6 Topics: alpha-Synuclein; Antiparkinson Agents; Apoptosis; Autophagy; Down-Regulation; Gene Expression Regulation; Humans; MicroRNAs; Parkinson Disease; Pramipexole; RNA, Messenger	2018
Drug-induced gambling disorder: A not so rare but underreported condition. Psychiatry research, 2018, Volume: 269 Topics: Aged; Aged, 80 and over; Dopamine Agonists; Gambling; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole	2018
Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease. Journal of pharmacological sciences, 2018, Volume: 138, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Cutaneous; Animals; Apoptosis; Corpus Striatum; Delayed-Action Preparations; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Male; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Pramipexole; Superoxide Dismutase; Transdermal Patch	2018
[Increased frequency and spread of restlessness as the early manifestation of Parkinson's disease in a woman with restless legs syndrome]. Rinsho shinkeigaku = Clinical neurology, 2018, Oct-24, Volume: 58, Issue:10 Topics: Benzothiazoles; Dopamine Agonists; Female; Heart; Humans; Middle Aged; Parkinson Disease; Pramipexole; Putamen; Restless Legs Syndrome; Tomography, Emission-Computed, Single-Photon	2018
Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography. Anatolian journal of cardiology, 2018, Volume: 20, Issue:4 Topics: Aged; Cross-Sectional Studies; Dopamine Agonists; Echocardiography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Turkey; Ventricular Dysfunction, Left	2018
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease. Parkinsonism & related disorders, 2019, Volume: 61 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Delayed-Action Preparations; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Sex Factors; Tetrahydronaphthalenes; Thiophenes	2019
Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease. Neurobiology of aging, 2019, Volume: 75 Topics: Animals; Corpus Striatum; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Impulsive Behavior; Motor Activity; Parkinson Disease; Parkinsonian Disorders; Pramipexole; Rats; Substantia Nigra	2019
Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System. Journal of gambling studies, 2020, Volume: 36, Issue:1 Topics: Adverse Drug Reaction Reporting Systems; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Gambling; Humans; Italy; Levodopa; Male; Parkinson Disease; Pramipexole	2020
Near-infrared light-responsive, pramipexole-loaded biodegradable PLGA microspheres for therapeutic use in Parkinson's disease. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2019, Volume: 141 Topics: Biodegradable Plastics; Capsules; Drug Delivery Systems; Drug Liberation; Emulsions; Humans; Infrared Rays; Microspheres; Nanospheres; Parkinson Disease; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Pramipexole; Solvents	2019
[Comparison of the Pharmaceutical Characteristics of Brand-name and Generic Pramipexole Extended-release Tablets and Their PTP Usability]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2019, Sep-01, Volume: 139, Issue:9 Topics: Antiparkinson Agents; Delayed-Action Preparations; Dopamine Agonists; Drug Packaging; Drug Stability; Drugs, Generic; Humans; Japan; Medication Adherence; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Surveys and Questionnaires; Tablets	2019
Text messaging as a new compulsive behavior in a patient with Parkinson's disease. Psychiatry and clinical neurosciences, 2013, Volume: 67, Issue:2 Topics: Adult; Antiparkinson Agents; Benzothiazoles; Compulsive Behavior; Humans; Male; Parkinson Disease; Pramipexole; Text Messaging	2013
Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy. Irish medical journal, 2013, Volume: 106, Issue:1 Topics: Adult; Amantadine; Antiparkinson Agents; Benzothiazoles; Carbidopa; Catechols; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pramipexole; Selegiline	2013
Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistry. NeuroImage, 2013, Oct-01, Volume: 79 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Levodopa; Longitudinal Studies; Male; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Parkinson Disease; Pramipexole; Presynaptic Terminals; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes	2013
Successful pregnancy and delivery in a patient with Parkinson's disease under pramipexole treatment. Presse medicale (Paris, France : 1983), 2014, Volume: 43, Issue:1 Topics: Adult; Antiparkinson Agents; Benzothiazoles; Female; Humans; Parkinson Disease; Pramipexole; Pregnancy; Pregnancy Complications; Pregnancy Outcome	2014
PROUD stands tall: delayed-start studies in Parkinson's disease. The Lancet. Neurology, 2013, Volume: 12, Issue:8 Topics: Antiparkinson Agents; Benzothiazoles; Female; Humans; Male; Parkinson Disease; Pramipexole	2013
Second-generation dopamine agonists and recollection impairments in Parkinson's disease. Journal of neuropsychology, 2013, Volume: 7, Issue:2 Topics: Aged; Attention; Benzothiazoles; Case-Control Studies; Dopamine Agonists; Female; Humans; Indoles; Male; Memory Disorders; Memory, Short-Term; Mental Recall; Middle Aged; Parkinson Disease; Pramipexole; Recognition, Psychology	2013
LC-MS/MS determination of pramipexole on rat dried blood spots: a pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013, Aug-01, Volume: 932 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Chromatography, Liquid; Dried Blood Spot Testing; Limit of Detection; Parkinson Disease; Pramipexole; Rats; Tandem Mass Spectrometry	2013
Dopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions. Human brain mapping, 2014, Volume: 35, Issue:6 Topics: Benzothiazoles; Brain; Brain Mapping; Choice Behavior; Dopamine Agonists; Female; Humans; Impulsive Behavior; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Pramipexole; Reward; Signal Processing, Computer-Assisted; Task Performance and Analysis	2014
Dopamine-agonist responsive Parkinsonism in a patient with the SANDO syndrome caused by POLG mutation. BMC medical genetics, 2013, Oct-07, Volume: 14 Topics: Benzothiazoles; DNA Mutational Analysis; DNA Polymerase gamma; DNA-Directed DNA Polymerase; Dopamine Agonists; Duloxetine Hydrochloride; Dysarthria; Female; Hereditary Sensory and Motor Neuropathy; Humans; Middle Aged; Mitochondria; Ophthalmoplegia; Parkinson Disease; Pramipexole; Thiophenes; Tomography, Emission-Computed, Single-Photon	2013
MitoPark mice, an animal model of Parkinson's disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A(2A) antagonist SCH 412348. Psychopharmacology, 2014, Volume: 231, Issue:7 Topics: Adenosine A2 Receptor Antagonists; Aging; Animals; Apomorphine; Benzothiazoles; Disease Models, Animal; Dopamine Agonists; Male; Mice; Mice, Transgenic; Motor Activity; Parkinson Disease; Pramipexole; Prepulse Inhibition; Pyrimidines; Triazoles	2014
Pramipexole: heart failure. Prescrire international, 2013, Volume: 22, Issue:141 Topics: Antiparkinson Agents; Benzothiazoles; Heart Failure; Humans; Parkinson Disease; Pramipexole; Restless Legs Syndrome; Risk	2013
Two cases of pregnancy in Parkinson's disease. Parkinsonism & related disorders, 2014, Volume: 20, Issue:2 Topics: Adult; Antiparkinson Agents; Benzothiazoles; Female; Fetus; Humans; Indoles; Parkinson Disease; Pramipexole; Pregnancy; Pregnancy Complications	2014
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study. Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:8 Topics: Administration, Cutaneous; Administration, Oral; Age Factors; Aged; Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sex Factors; Tetrahydronaphthalenes; Thiophenes	2014
Pramipexole reverses Parkinson's disease-related motivational deficits in rats. Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:7 Topics: Animals; Apathy; Behavior, Animal; Benzothiazoles; Brain; Disease Models, Animal; Dopamine; Dopamine Agonists; Parkinson Disease; Pramipexole; Rats; Receptors, Dopamine	2014
Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2014, Volume: 88, Issue:1 Topics: Administration, Cutaneous; Animals; Antioxidants; Benzothiazoles; Chromatography, High Pressure Liquid; Ear, External; Electrochemistry; Electroosmosis; Gels; Humans; Iontophoresis; Kinetics; Male; Neurodegenerative Diseases; Parkinson Disease; Pramipexole; Rats; Rats, Wistar; Skin; Sulfites; Swine	2014
Hypnotherapy for persistent genital arousal disorder: a case study. The International journal of clinical and experimental hypnosis, 2014, Volume: 62, Issue:2 Topics: Aged; Antiparkinson Agents; Autogenic Training; Benzothiazoles; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypnosis; Parkinson Disease; Pramipexole; Relaxation Therapy; Sexual Dysfunctions, Psychological; Suggestion	2014
Pramipexole but not imipramine or fluoxetine reverses the "depressive-like" behaviour in a rat model of preclinical stages of Parkinson's disease. Behavioural brain research, 2014, Sep-01, Volume: 271 Topics: Animals; Antidepressive Agents; Benzothiazoles; Depression; Disease Models, Animal; Dopamine Agonists; Fluoxetine; Imipramine; Male; Motor Activity; Oxidopamine; Parkinson Disease; Pramipexole; Rats; Rats, Wistar; Swimming; Treatment Outcome	2014
[Mania with psychotic feature induced by the use of pramipexole in Parkinson's disease: a case report]. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2014,Fall, Volume: 25, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Bipolar Disorder; Diagnosis, Differential; Humans; Parkinson Disease; Pramipexole; Psychiatric Status Rating Scales	2014
Restless genital syndrome in Parkinson disease. JAMA neurology, 2014, Volume: 71, Issue:12 Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Genital Diseases, Female; Humans; Parkinson Disease; Pramipexole; Syndrome	2014
Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA internal medicine, 2014, Volume: 174, Issue:12 Topics: Adult; Aged; Aripiprazole; Benzothiazoles; Compulsive Behavior; Consumer Behavior; Dopamine Agonists; Drug Labeling; Female; Gambling; Humans; Hyperprolactinemia; Impulsive Behavior; Indoles; Male; Middle Aged; Parkinson Disease; Piperazines; Pramipexole; Quinolones; Receptors, Dopamine D3; Restless Legs Syndrome; Retrospective Studies; Sexual Behavior; United States; United States Food and Drug Administration	2014
Auditory musical hallucinations associated with extended-release pramipexole in an elderly patient with Parkinson's disease. Medicine, 2014, Volume: 93, Issue:27 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Female; Hallucinations; Humans; Music; Parkinson Disease; Pramipexole	2014
Neuropsychological findings in a case of punding before and after cessation of pramipexole. The Clinical neuropsychologist, 2015, Volume: 29, Issue:1 Topics: Benzothiazoles; Cognitive Behavioral Therapy; Compulsive Behavior; Dopamine Agonists; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole	2015
Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats. PloS one, 2015, Volume: 10, Issue:3 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Brain; Brain-Derived Neurotrophic Factor; Male; Oxidopamine; Parkinson Disease; Pramipexole; Rats; Rats, Wistar; Receptor, trkB; RNA, Messenger	2015
[Dyskinesia-hyperpyrexia syndrome in a patient with Parkinson's disease: a case report]. Rinsho shinkeigaku = Clinical neurology, 2015, Volume: 55, Issue:3 Topics: Aged; Benzothiazoles; Delayed-Action Preparations; Drug Substitution; Drug Therapy, Combination; Female; Fever; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pramipexole; Selegiline	2015
Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients. Drugs & aging, 2015, Volume: 32, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Apathy; Benzothiazoles; Cross-Sectional Studies; Dopamine Agonists; Educational Status; Female; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Prospective Studies; Psychotropic Drugs; Spain	2015
Contrasting gene expression patterns induced by levodopa and pramipexole treatments in the rat model of Parkinson's disease. Neuropharmacology, 2016, Volume: 101 Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Benzothiazoles; Cluster Analysis; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Levodopa; Male; Microarray Analysis; Oxidopamine; Parkinson Disease; Pramipexole; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase	2016
Variable frequency stimulation of subthalamic nucleus for freezing of gait in Parkinson's disease. Parkinsonism & related disorders, 2015, Volume: 21, Issue:12 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Combined Modality Therapy; Deep Brain Stimulation; Dopamine Agonists; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Pramipexole; Subthalamic Nucleus	2015
A case of severe leg oedema in a patient with Parkinson's disease treated with pramipexole. Postgraduate medical journal, 2016, Volume: 92, Issue:1090 Topics: Antiparkinson Agents; Benzothiazoles; Carbidopa; Drug Combinations; Drug Therapy, Combination; Edema; Humans; Leg; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Treatment Outcome	2016
Validated UHPLC-MS/MS method for the simultaneous determination of pramipexole and ropinirole in plasma of patients with Parkinson's disease. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2016, Apr-01, Volume: 1017-1018 Topics: Antiparkinson Agents; Benzothiazoles; Chromatography, High Pressure Liquid; Humans; Indoles; Parkinson Disease; Pramipexole; Tandem Mass Spectrometry	2016
A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists. European journal of neurology, 2016, Volume: 23, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Surveys and Questionnaires	2016
Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients. NeuroImage. Clinical, 2016, Volume: 12 Topics: Aged; Benzamides; Benzothiazoles; Dopamine Agonists; Dopamine Antagonists; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Pramipexole; Radiopharmaceuticals; Receptors, Dopamine D2; Receptors, Dopamine D3	2016
Pramipexole-associated fixed limb dystonia in Parkinson's disease. Parkinsonism & related disorders, 2016, Volume: 31 Topics: Antiparkinson Agents; Benzothiazoles; Dystonia; Female; Humans; Middle Aged; Parkinson Disease; Pramipexole	2016
Association of the DRD2 CA Journal of the neurological sciences, 2017, Jan-15, Volume: 372 Topics: Aged; Aged, 80 and over; Analysis of Variance; Benzothiazoles; Case-Control Studies; Dinucleotide Repeats; Dopamine Agonists; Female; Genotype; Glycine; Humans; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Serine	2017
Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release. Neuropharmacology, 2017, 03-01, Volume: 114 Topics: Animals; Benzothiazoles; Caudate Nucleus; Decision Making; Dopamine; Male; Norepinephrine; Nucleus Accumbens; Parkinson Disease; Pramipexole; Prefrontal Cortex; Probability; Putamen; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Risk-Taking; Serotonin	2017
Analysis of pramipexole dose-response relationships in Parkinson's disease. Drug design, development and therapy, 2017, Volume: 11 Topics: Antiparkinson Agents; Benzothiazoles; Dose-Response Relationship, Drug; Humans; Parkinson Disease; Pramipexole; Retrospective Studies	2017
Reduced Activated T Lymphocytes (CD4+CD25+) and Plasma Levels of Cytokines in Parkinson's Disease. Molecular neurobiology, 2018, Volume: 55, Issue:2 Topics: Aged; Antiparkinson Agents; CD4-Positive T-Lymphocytes; Cytokines; Female; Humans; Immunophenotyping; Leukocytes, Mononuclear; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole	2018
Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion. Scientific reports, 2017, 03-14, Volume: 7 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzothiazoles; Dextroamphetamine; Disease Models, Animal; Dopamine; Hippocampus; Humans; Long-Term Potentiation; Mice; Parkinson Disease; Pramipexole; Substantia Nigra; Synaptic Transmission; Temporal Lobe; Ventral Tegmental Area	2017
Correspondence: The pathophysiology of pramipexole-associated dystonia in patients with Parkinson's disease. Parkinsonism & related disorders, 2017, Volume: 38 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dystonia; Humans; Levodopa; Parkinson Disease; Pramipexole	2017
Pramipexole associated dystonia. Parkinsonism & related disorders, 2017, Volume: 38 Topics: Benzothiazoles; Dopamine Agonists; Dystonia; Dystonic Disorders; Humans; Parkinson Disease; Pramipexole; Thiazoles	2017
A 77-year-old man with Parkinson's disease and hyperthermia. Journal of emergency nursing, 2008, Volume: 34, Issue:3 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Combined Modality Therapy; Emergency Service, Hospital; Emergency Treatment; Follow-Up Studies; Humans; Levodopa; Male; Malignant Hyperthermia; Neuroleptic Malignant Syndrome; Parkinson Disease; Pramipexole; Risk Assessment; Treatment Outcome	2008
[Mirapex (pramipexole) in the treatment of non-motor disturbances in Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:5 Topics: Antiparkinson Agents; Anxiety; Benzothiazoles; Depression; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Sleep Wake Disorders; Treatment Outcome	2008
Discontinuation of ropinirole and pramipexole in patients with Parkinson's disease: clinical practice versus clinical trials. European journal of clinical pharmacology, 2008, Volume: 64, Issue:10 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cohort Studies; Female; Follow-Up Studies; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Patient Compliance; Practice Guidelines as Topic; Pramipexole; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome	2008
Fatal intoxication using amantadine and pramipexole in a uremic patient. Acta neurologica Taiwanica, 2008, Volume: 17, Issue:2 Topics: Amantadine; Antiparkinson Agents; Benzothiazoles; Fatal Outcome; Female; Humans; Middle Aged; Parkinson Disease; Pramipexole; Uremia	2008
Heart valve abnormalities in Parkinson's disease treated with dopamine agonists. Journal of neurology, 2008, Volume: 255, Issue:10 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Echocardiography; Female; Heart Valve Diseases; Heart Valves; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole	2008
Unraveling depression in Parkinson's disease. European journal of neurology, 2008, Volume: 15, Issue:9 Topics: Antidepressive Agents; Benzothiazoles; Clinical Trials as Topic; Cohort Studies; Depression; Depressive Disorder; Dopamine; Dopamine Agonists; Drug Interactions; Humans; Multicenter Studies as Topic; Parkinson Disease; Pramipexole; Quality of Life; Serotonin; Sertraline	2008
Dopaminergic modulation of semantic priming in Parkinson disease. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2008, Volume: 21, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2	2008
Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease. Sleep, 2008, Volume: 31, Issue:10 Topics: Aged; Antiparkinson Agents; Arousal; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Polysomnography; Pramipexole; Prospective Studies; REM Sleep Behavior Disorder; Video Recording	2008
Hiccups and dopamine. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Nov-15, Volume: 65, Issue:22 Topics: Amantadine; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Dopamine Antagonists; Hiccup; Humans; Parkinson Disease; Perphenazine; Pramipexole	2008
Pramipexole-induced dropped head syndrome in Parkinson's disease. Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:22 Topics: Aged; Benzothiazoles; Female; Head Movements; Humans; Parkinson Disease; Pramipexole; Syndrome	2008
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:2 Topics: Age Factors; Aged; Benzothiazoles; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Hypertension; Male; Parkinson Disease; Pergolide; Pramipexole; Risk Factors	2009
Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report. European journal of neurology, 2009, Volume: 16, Issue:2 Topics: Aged; Antiparkinson Agents; Azepines; Benzothiazoles; Cabergoline; Carbidopa; Catatonia; Catechols; Drug Therapy, Combination; Electroconvulsive Therapy; Ergolines; Female; Humans; Levodopa; Nitriles; Parkinson Disease; Pramipexole	2009
[Pathological gambling induced by dopamine agonist]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2009, Jan-10, Volume: 98, Issue:1 Topics: Benzothiazoles; Dopamine Agonists; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole	2009
[Impulse control disorder induced by the use of dopamine agonists]. Nederlands tijdschrift voor geneeskunde, 2009, Jan-17, Volume: 153, Issue:3 Topics: Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Restless Legs Syndrome; Risk Factors	2009
Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity. Journal of neurology, 2009, Volume: 256, Issue:5 Topics: Antiparkinson Agents; Arm; Art; Benzothiazoles; Brain; Cabergoline; Creativity; Depressive Disorder; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Motor Skills; Obsessive Behavior; Paintings; Parkinson Disease; Pramipexole	2009
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy. Journal of neurology, 2009, Volume: 256, Issue:3 Topics: Aged; Aged, 80 and over; Benserazide; Benzothiazoles; Brain; Carbidopa; Dopamine Agents; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Tomography, Emission-Computed, Single-Photon; Tropanes	2009
Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clinic proceedings, 2009, Volume: 84, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Compulsive Behavior; Dopamine Agonists; Female; Gambling; Humans; Indoles; Levodopa; Libido; Male; Middle Aged; Parkinson Disease; Pramipexole; Retrospective Studies	2009
Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson's disease patients. European journal of clinical pharmacology, 2009, Volume: 65, Issue:7 Topics: Aged; Alleles; Asian People; Benzothiazoles; DNA; Dopamine Agonists; Drug Administration Schedule; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Parkinson Disease; Polymorphism, Genetic; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Treatment Outcome	2009
Long-term retention rate of pramipexole in the treatment of Parkinson's disease. European journal of clinical pharmacology, 2009, Volume: 65, Issue:9 Topics: Antiparkinson Agents; Benzothiazoles; Confusion; Dopamine Agonists; Finland; Hallucinations; Humans; Medication Adherence; Nausea; Netherlands; Parkinson Disease; Pramipexole; Retrospective Studies; Risk Factors	2009
Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain : a journal of neurology, 2009, Volume: 132, Issue:Pt 9 Topics: Adult; Avoidance Learning; Benzothiazoles; Cross-Sectional Studies; Dopamine Agonists; Exploratory Behavior; Feedback, Psychological; Female; Follow-Up Studies; Humans; Indoles; Learning; Male; Middle Aged; Parkinson Disease; Personality; Personality Assessment; Pramipexole; Reward	2009
Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions. Movement disorders : official journal of the Movement Disorder Society, 2009, Sep-15, Volume: 24, Issue:12 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Drug Therapy, Combination; Follow-Up Studies; Gambling; Humans; Levodopa; Male; Parkinson Disease; Pramipexole	2009
Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease. European journal of clinical pharmacology, 2009, Volume: 65, Issue:12 Topics: Aged; Alleles; Benzothiazoles; Cohort Studies; Contraindications; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pharmacogenetics; Polymorphism, Single Nucleotide; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3	2009
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. Journal of the neurological sciences, 2009, Dec-15, Volume: 287, Issue:1-2 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Indoles; Levodopa; Male; Memory Disorders; Middle Aged; Mood Disorders; Movement Disorders; Neurologic Examination; Nocturia; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Prevalence; Restless Legs Syndrome; Treatment Outcome	2009
Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: an economic Markov model evaluation. Drugs & aging, 2009, Volume: 26, Issue:9 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Cost-Benefit Analysis; Disease Progression; Dopamine Agonists; Female; Health Care Costs; Humans; Indans; Insurance, Health, Reimbursement; Male; Markov Chains; Middle Aged; Models, Economic; Monoamine Oxidase Inhibitors; Monte Carlo Method; Parkinson Disease; Pramipexole; Probability; Quality-Adjusted Life Years; State Medicine; Treatment Outcome; United Kingdom	2009
[Influence of dopamine agonist pramipexole (mirapex) on tremor, cognitive and affective impairment in patients with Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:8 Topics: Adult; Affect; Aged; Benzothiazoles; Cognition; Cognition Disorders; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mood Disorders; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Treatment Outcome; Tremor	2009
[Fatigability in Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:9 Topics: Activities of Daily Living; Antiparkinson Agents; Benzothiazoles; Fatigue; Humans; Middle Aged; Parkinson Disease; Pramipexole; Prognosis; Receptors, Dopamine D1; Surveys and Questionnaires	2009
Pramipexole and gender identity disorder: expanding the phenotype of hypersexuality in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Dec-15, Volume: 24, Issue:16 Topics: Adult; Antiparkinson Agents; Benzothiazoles; Gender Identity; Humans; Male; Parkinson Disease; Phenotype; Pramipexole; Sexual Dysfunctions, Psychological	2009
Dopamine agonist induced compulsive eating behaviour in a Parkinson's disease patient. Pharmacy world & science : PWS, 2010, Volume: 32, Issue:2 Topics: Benzothiazoles; Compulsive Behavior; Diabetes Mellitus, Type 2; Dopamine Agonists; Feeding and Eating Disorders; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole	2010
Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:4 Topics: Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Impulsive Behavior; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Schizophrenia, Paranoid; Smoking	2010
Patent watch. Nature reviews. Drug discovery, 2010, Volume: 9, Issue:3 Topics: Antineoplastic Agents, Alkylating; Antiparkinson Agents; Benzothiazoles; Brain Neoplasms; Dacarbazine; Humans; Parkinson Disease; Patents as Topic; Pramipexole; Temozolomide; Time Factors	2010
Continuous dopaminergic stimulation by pramipexole is effective to treat early morning akinesia in animal models of Parkinson's disease: A pharmacokinetic-pharmacodynamic study using in vivo microdialysis in rats. Synapse (New York, N.Y.), 2010, Volume: 64, Issue:7 Topics: Animals; Benzothiazoles; Catalepsy; Delayed-Action Preparations; Disease Models, Animal; Dopamine; Dopamine Agonists; Dyskinesia, Drug-Induced; Extracellular Space; Haloperidol; Infusion Pumps, Implantable; Injections, Subcutaneous; Male; Parkinson Disease; Parkinsonian Disorders; Photoperiod; Pramipexole; Rats; Rats, Wistar; Reserpine; Time Factors	2010
Pramipexole for depression and motor symptoms in Parkinson's disease: can we kill two birds with one stone? The Lancet. Neurology, 2010, Volume: 9, Issue:6 Topics: Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Depressive Disorder; Dopamine Agonists; Dyskinesias; Humans; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic	2010
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Archives of neurology, 2010, Volume: 67, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Binge-Eating Disorder; Comorbidity; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prevalence; Risk Factors; Sexual Dysfunctions, Psychological	2010
[Effects of the dopamine agonist mirapex (pramipexole) therapy on sleep disorders in Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:3 Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep Wake Disorders	2010
Isolated delusional syndrome in Parkinson's Disease. Parkinsonism & related disorders, 2010, Volume: 16, Issue:8 Topics: Aged; Amantadine; Antiparkinson Agents; Benserazide; Benzothiazoles; Catechols; Clonazepam; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Pramipexole; Schizophrenia, Paranoid; Syndrome	2010
Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease. Neurochemical research, 2010, Volume: 35, Issue:10 Topics: Acetylcysteine; Animals; Autophagy; Benzothiazoles; Brain-Derived Neurotrophic Factor; Corpus Striatum; Dopamine; Dopamine Agonists; Glial Cell Line-Derived Neurotrophic Factor; Male; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Receptors, Dopamine D3; Substantia Nigra; Ubiquitin	2010
[Pathologic gambling as an adverse effect of the treatment for Parkinson's disease]. Revista medica de Chile, 2010, Volume: 138, Issue:4 Topics: Antiparkinson Agents; Benzothiazoles; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole	2010
Clozapine for medication-related pathological gambling in Parkinson disease. Movement disorders : official journal of the Movement Disorder Society, 2010, Sep-15, Volume: 25, Issue:12 Topics: Adult; Antiparkinson Agents; Benzothiazoles; Cabergoline; Clozapine; Ergolines; Female; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Selegiline; Serotonin Antagonists	2010
Exercise dependence induced by pramipexole in Parkinson's Disease-a case report. Movement disorders : official journal of the Movement Disorder Society, 2010, Dec-15, Volume: 25, Issue:16 Topics: Aged; Antiparkinson Agents; Behavior, Addictive; Benzothiazoles; Exercise; Humans; Male; Neuropsychological Tests; Parkinson Disease; Pramipexole	2010
Dopamine agonists and Othello's syndrome. Parkinsonism & related disorders, 2010, Volume: 16, Issue:10 Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Benzothiazoles; Delusions; Dopamine Agonists; Female; Gambling; Humans; Male; Marriage; Middle Aged; Parkinson Disease; Pramipexole; Syndrome	2010
Cost effectiveness of rasagiline and pramipexole as treatment strategies in early Parkinson's disease in the UK setting: An economic Markov model evaluation. Drugs & aging, 2011, Feb-01, Volume: 28, Issue:2 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cost-Benefit Analysis; Dopamine Agonists; Humans; Indans; Markov Chains; Models, Economic; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; United Kingdom	2011
Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies. Parkinsonism & related disorders, 2011, Volume: 17, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Compulsive Behavior; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole	2011
Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson's disease patients. Neuro endocrinology letters, 2011, Volume: 32, Issue:1 Topics: Aged; Arginine Vasopressin; Benzothiazoles; Carbidopa; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole	2011
Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance. Neuroscience letters, 2011, Aug-15, Volume: 500, Issue:2 Topics: Aged; Benserazide; Benzothiazoles; Carbidopa; Cues; Deep Brain Stimulation; Dopamine Agents; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Psychomotor Performance; Reaction Time; Subthalamic Nucleus	2011
The effect of pramipexole on depressive symptoms in Parkinson's disease. The Kobe journal of medical sciences, 2011, Feb-02, Volume: 56, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Depression; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole	2011
Panic attack-like episodes possibly induced by pramipexole in a patient with young-onset Parkinson's disease. The Journal of neuropsychiatry and clinical neurosciences, 2011,Summer, Volume: 23, Issue:3 Topics: Adult; Antiparkinson Agents; Benzothiazoles; Humans; Male; Panic Disorder; Parkinson Disease; Pramipexole	2011
Anhedonia in Japanese patients with Parkinson's disease: analysis using the Snaith-Hamilton Pleasure Scale. Clinical neurology and neurosurgery, 2012, Volume: 114, Issue:4 Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Anhedonia; Antiparkinson Agents; Benzothiazoles; Female; Humans; Japan; Linear Models; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pleasure; Pramipexole; Sex Factors	2012
Novel extraction technique to remove a penile constriction device. The journal of sexual medicine, 2012, Volume: 9, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Constriction; Edema; Foreign Bodies; Humans; Male; Middle Aged; Paraphilic Disorders; Parkinson Disease; Penis; Pramipexole; Tourniquets; Urologic Surgical Procedures, Male	2012
Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson's disease and controls. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:6 Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Benzothiazoles; Biophysics; Conditioning, Operant; Disease Models, Animal; Disruptive, Impulse Control, and Conduct Disorders; Electric Stimulation; Electrodes, Implanted; Male; Motor Activity; Oxidopamine; Parkinson Disease; Pramipexole; Probability Learning; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Risk-Taking; Self Administration	2012
Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause? The journal of headache and pain, 2012, Volume: 13, Issue:3 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Burning Mouth Syndrome; Carbidopa; Dopamine; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Parkinson Disease; Pramipexole	2012
Reversible antecollis associated with pramipexole in a patient with Parkinson's disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2012, Volume: 19, Issue:6 Topics: Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Dyskinesia, Drug-Induced; Electromyography; Female; Humans; Muscle Rigidity; Neck Muscles; Parkinson Disease; Pramipexole	2012
New dopamine agonist pramipexole improves parkinsonism and depression in Parkinson's disease. Hiroshima journal of medical sciences, 2011, Volume: 60, Issue:4 Topics: Aged; Aged, 80 and over; Benzothiazoles; Depression; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole	2011
Finasteride attenuates pathological gambling in patients with Parkinson disease. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:3 Topics: 5-alpha Reductase Inhibitors; Aged; Antiparkinson Agents; Benzothiazoles; Cabergoline; Carbidopa; Catechols; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Ergolines; Finasteride; Gambling; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Pramipexole; Treatment Outcome; Video Games	2012
Dopamine dysregulation syndrome including mania related to coadministration of droxidopa. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:3 Topics: Aggression; Antiparkinson Agents; Behavior, Addictive; Benzothiazoles; Bipolar Disorder; Carbidopa; Droxidopa; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Neurotoxicity Syndromes; Parkinson Disease; Pramipexole; Treatment Outcome	2012
Dosing issues in Parkinson's disease--patient preferences and their influence on compliance. European journal of neurology, 2013, Volume: 20, Issue:1 Topics: Antiparkinson Agents; Benzothiazoles; Female; Humans; Male; Parkinson Disease; Pramipexole; Self Report	2013
Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2012, Volume: 19, Issue:9 Topics: Ankle; Antiparkinson Agents; Benserazide; Benzothiazoles; Drug Therapy, Combination; Edema; Humans; Levodopa; Lower Extremity; Male; Middle Aged; Parkinson Disease; Pramipexole; Selegiline	2012
Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls. Behavioural brain research, 2012, Jul-15, Volume: 233, Issue:1 Topics: Adrenergic Agents; Analysis of Variance; Animals; Association Learning; Benzothiazoles; Conditioning, Operant; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Forelimb; Male; Methamphetamine; Motor Activity; Nucleus Accumbens; Oxidopamine; Parkinson Disease; Pramipexole; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reward; Tyrosine 3-Monooxygenase	2012
Spontaneous unwelcome orgasms due to pramipexole and ropinirole. Movement disorders : official journal of the Movement Disorder Society, 2012, Sep-01, Volume: 27, Issue:10 Topics: Antiparkinson Agents; Benzothiazoles; Female; Humans; Indoles; Middle Aged; Nervous System Diseases; Orgasm; Parkinson Disease; Pramipexole	2012
Caffeine drinking, cigarette smoking, and dopaminergic replacement therapy dose in Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013, Volume: 34, Issue:6 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Caffeine; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Smoking; Statistics as Topic	2013
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease. Scottish medical journal, 2012, Volume: 57, Issue:4 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Dizziness; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Time Factors	2012
Pramipexole use and the risk of pneumonia. BMC neurology, 2012, Sep-29, Volume: 12 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cohort Studies; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Middle Aged; Parkinson Disease; Pneumonia; Pramipexole; Registries; Risk Factors; United Kingdom	2012
Potential reliability and validity of a modified version of the Unified Parkinson's Disease Rating Scale that could be administered remotely. Parkinsonism & related disorders, 2013, Volume: 19, Issue:2 Topics: Antiparkinson Agents; Benzothiazoles; Humans; Levodopa; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Reproducibility of Results; Severity of Illness Index; Telemedicine; Tremor	2013
Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding. Behavioural neurology, 2013, Jan-01, Volume: 27, Issue:4 Topics: Aged; Benzothiazoles; Compulsive Behavior; Dopamine Agonists; Humans; Male; Parkinson Disease; Pramipexole	2013
Dopamine dysregulation syndrome in Parkinson's disease patients with unsatisfactory switching from immediate to extended release pramipexole: a further clue to incentive sensitization mechanisms? Behavioural neurology, 2013, Jan-01, Volume: 27, Issue:4 Topics: Aged; Behavior, Addictive; Benzothiazoles; Delayed-Action Preparations; Dopamine; Dopamine Agonists; Humans; Male; Middle Aged; Mood Disorders; Parkinson Disease; Pramipexole; Syndrome	2013
Brain imaging to assess the effects of dopamine agonists on progression of Parkinson disease. JAMA, 2002, Jul-17, Volume: 288, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Brain; Cocaine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed, Single-Photon	2002
[Pramipexole in Parkinson disease. Results of a treatment observation]. Der Nervenarzt, 2002, Volume: 73, Issue:8 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Dopamine Agonists; Female; Humans; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pramipexole; Product Surveillance, Postmarketing; Receptors, Dopamine D2; Thiazoles; Treatment Outcome	2002
Loss of color vision during long-term treatment with pramipexole. Journal of neurology, 2003, Volume: 250, Issue:1 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Color Vision Defects; Humans; Male; Parkinson Disease; Pramipexole; Thiazoles; Time Factors	2003
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2003, Volume: 74, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Caudate Nucleus; Cocaine; Corpus Striatum; Disease Progression; Female; Humans; Male; Nerve Degeneration; Parkinson Disease; Pergolide; Pramipexole; Putamen; Radiopharmaceuticals; Receptors, Dopamine D2; Reproducibility of Results; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome	2003
The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa. Age and ageing, 2003, Volume: 32, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Thiazoles	2003
REAL and CALM: what have we learned? Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:7 Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Corpus Striatum; Disease Progression; Dopamine; Feasibility Studies; Humans; Indoles; Levodopa; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Putamen; Reference Values; Sensitivity and Specificity; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2003
Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology, 2003, Aug-12, Volume: 61, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Female; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Recurrence; Retrospective Studies; Suicide; Thiazoles	2003
Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson's neurodegeneration. European journal of pharmacology, 2003, Aug-08, Volume: 474, Issue:2-3 Topics: Animals; Benzothiazoles; Corpus Striatum; Dopamine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Degeneration; Neuropeptides; Parkinson Disease; Pramipexole; Rats; Rats, Sprague-Dawley; Synaptic Vesicles; Thiazoles; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2003
Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease. CNS drugs, 2003, Volume: 17, Issue:13 Topics: Activities of Daily Living; Aged; Benzothiazoles; Clinical Trials, Phase III as Topic; Female; Humans; Male; Middle Aged; Muscle Rigidity; Observation; Parkinson Disease; Pramipexole; Prospective Studies; Statistics, Nonparametric; Thiazoles	2003
Oral anticoagulation for ECG tremor artefact simulating atrial fibrillation. Acta cardiologica, 2003, Volume: 58, Issue:5 Topics: Aged; Anticoagulants; Antiparkinson Agents; Atrial Fibrillation; Benzothiazoles; Diagnosis, Differential; Diagnostic Errors; Electrocardiography; Female; Humans; Parkinson Disease; Phenprocoumon; Pramipexole; Thiazoles	2003
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Archives of neurology, 2004, Volume: 61, Issue:1 Topics: Aged; Benzothiazoles; Bromocriptine; Disorders of Excessive Somnolence; Dopamine Agonists; Dose-Response Relationship, Drug; Ergot Alkaloids; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Polysomnography; Pramipexole; Prospective Studies; Sleep; Thiazoles; Wakefulness	2004
Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology, 2004, Jan-27, Volume: 62, Issue:2 Topics: Antiparkinson Agents; Artifacts; Benzothiazoles; Clinical Trials as Topic; Disease Progression; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Pramipexole; Severity of Illness Index; Single-Blind Method; Thiazoles	2004
Slowing Parkinson's disease progression: recent dopamine agonist trials. Neurology, 2004, Jan-27, Volume: 62, Issue:2 Topics: Antiparkinson Agents; Benzothiazoles; Biological Transport; Cell Line, Tumor; Clinical Trials as Topic; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Indoles; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuroblastoma; Parkinson Disease; Pramipexole; Thiazoles	2004
Pramipexole-treated Parkinson's disease during pregnancy. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:9 Topics: Adult; Benzothiazoles; Dopamine Agonists; Female; Humans; Parkinson Disease; Pramipexole; Pregnancy; Pregnancy Complications; Severity of Illness Index; Thiazoles	2004
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles	2004
Predictors of sudden onset of sleep in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Comorbidity; Cross-Sectional Studies; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pramipexole; Risk Factors; Surveys and Questionnaires; Thiazoles	2004
Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor. BMC biology, 2004, Oct-11, Volume: 2 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Down-Regulation; Injections, Subcutaneous; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Fibers; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Receptors, Dopamine D3; Thiazoles	2004
"Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease. Neurology, 2005, Mar-08, Volume: 64, Issue:5 Topics: Aged; Amantadine; Benzothiazoles; Catechols; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Iatrogenic Disease; Indoles; Levodopa; Male; Middle Aged; Neurology; Neuropharmacology; Neurotoxicity Syndromes; Nitriles; Parkinson Disease; Pramipexole; Selegiline; Thiazoles; Treatment Outcome	2005
Pramipexole, ropinirole, and mania in Parkinson's disease. The American journal of psychiatry, 2005, Volume: 162, Issue:4 Topics: Adult; Antiparkinson Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2005
Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopamine-semiquinone generated in vitro. Neurological research, 2005, Volume: 27, Issue:5 Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antiparkinson Agents; Benzoquinones; Benzothiazoles; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Electron Spin Resonance Spectroscopy; Functional Laterality; Homovanillic Acid; Levodopa; Male; Mice; Mice, Inbred ICR; Oxidopamine; Parkinson Disease; Pramipexole; Thiazoles; Time Factors	2005
Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease. Archives of neurology, 2005, Volume: 62, Issue:8 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Drug Administration Schedule; Humans; Lung; Male; Molecular Structure; Parkinson Disease; Pergolide; Pleura; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Thiazoles; Tomography, X-Ray Computed	2005
Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors. Synapse (New York, N.Y.), 2005, Volume: 58, Issue:2 Topics: Animals; Benzothiazoles; Binding, Competitive; Brain; Cells, Cultured; Cricetinae; Domperidone; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Mice; Neurons; Oxazines; Parkinson Disease; Pramipexole; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Synapses; Synaptic Transmission; Thiazoles; Tritium	2005
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism & related disorders, 2005, Volume: 11, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Catechols; Databases, Factual; Dopamine Agonists; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Multiple System Atrophy; Nitriles; Parkinson Disease; Pramipexole; Sexual Dysfunctions, Psychological; Thiazoles	2005
[Syndrome of inappropriate ADH secretion (SIADH) induced by pramipexole in a patient with Parkinson's disease]. Nihon Jinzo Gakkai shi, 2005, Volume: 47, Issue:5 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Female; Humans; Parkinson Disease; Pituitary ACTH Hypersecretion; Pramipexole; Thiazoles	2005
Pathological gambling in Parkinson's disease. The Lancet. Neurology, 2005, Volume: 4, Issue:10 Topics: Antiparkinson Agents; Benzothiazoles; Brain; Dopamine Agonists; Dose-Response Relationship, Drug; Gambling; Humans; Indoles; Mental Disorders; Neural Pathways; Parkinson Disease; Pramipexole; Thiazoles	2005
Gambling and Parkinson disease. Archives of neurology, 2006, Volume: 63, Issue:2 Topics: Antiparkinson Agents; Benzothiazoles; Gambling; Humans; Levodopa; Parkinson Disease; Pramipexole; Risk Factors; Thiazoles	2006
Hiccups associated with dopamine agonists in Parkinson disease. Neurology, 2006, Mar-14, Volume: 66, Issue:5 Topics: Aged; Benzothiazoles; Dopamine Agonists; Hiccup; Humans; Male; Parkinson Disease; Pergolide; Pramipexole; Thiazoles	2006
Chronic cluster headache responsive to pramipexole. Cephalalgia : an international journal of headache, 2006, Volume: 26, Issue:6 Topics: Antiparkinson Agents; Benzothiazoles; Cluster Headache; Dopamine Agonists; Humans; Incidental Findings; Male; Middle Aged; Parkinson Disease; Pramipexole; Thiazoles; Treatment Outcome	2006
Reversal learning in Parkinson's disease depends on medication status and outcome valence. Neuropsychologia, 2006, Volume: 44, Issue:10 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Case-Control Studies; Female; Humans; Learning Disabilities; Male; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Reversal Learning; Thiazoles	2006
A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease. Journal of the neurological sciences, 2006, Oct-25, Volume: 248, Issue:1-2 Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Case-Control Studies; Cognition; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole	2006
Association of dopamine agonist use with impulse control disorders in Parkinson disease. Archives of neurology, 2006, Volume: 63, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Follow-Up Studies; Gambling; Humans; Indoles; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Thiazoles	2006
[Dopamine receptors agonists (mirapex) in the treatment of Parkinson's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2006, Volume: 106, Issue:6 Topics: Anxiety; Benzothiazoles; Carbidopa; Delayed-Action Preparations; Depression; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Thiazoles; Treatment Outcome	2006
Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease. Parkinsonism & related disorders, 2007, Volume: 13, Issue:6 Topics: Adult; Benzothiazoles; Deep Brain Stimulation; Dopamine Agonists; Gambling; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Subthalamic Nucleus	2007
Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:5 Suppl Topics: Alopecia; Antiparkinson Agents; Benzothiazoles; Female; Hair Follicle; Humans; Middle Aged; Parkinson Disease; Pramipexole; Scalp	2006
Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity. European journal of pharmacology, 2007, Feb-28, Volume: 557, Issue:2-3 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Cell Survival; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Glutamic Acid; Immunohistochemistry; Mesencephalon; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Rats	2007
[7-year experience in usage of mirapex in patients with different forms of primary parkinsonism]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2006, Volume: 106, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Receptors, Dopamine D1; Time Factors; Treatment Outcome	2006
Drug adverse events and drop-out risk: a clinical case. Archives of gerontology and geriatrics, 2007, Volume: 44 Suppl 1 Topics: Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Benzothiazoles; Brain; Dopamine Agonists; Drug Therapy; Female; Health Status; Humans; Magnetic Resonance Imaging; Mental Disorders; Parkinson Disease; Patient Dropouts; Pramipexole; Promazine; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index	2007
Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease. Archives of neurology, 2007, Volume: 64, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Case-Control Studies; Echocardiography; Female; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole	2007
Risk factors for the development of pedal edema in patients using pramipexole. Archives of neurology, 2007, Volume: 64, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cohort Studies; Coronary Artery Disease; Diabetes Complications; Dopamine Agonists; Edema; Foot Diseases; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Medical Records; Middle Aged; Parkinson Disease; Pramipexole; Proportional Hazards Models; Retrospective Studies; Risk Factors	2007
Panic attack like episodes possibly associated with pramipexole therapy in Parkinson's disease. European journal of neurology, 2007, Volume: 14, Issue:5 Topics: Anxiety Disorders; Benzothiazoles; Carbidopa; Central Nervous System; Diazepam; Dopamine Agonists; Dose-Response Relationship, Drug; Female; GABA Agonists; Humans; Levodopa; Middle Aged; Panic Disorder; Parkinson Disease; Pramipexole; Self Administration	2007
Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study. Neurology, 2007, Jul-03, Volume: 69, Issue:1 Topics: Antiparkinson Agents; Benzothiazoles; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Male; Parkinson Disease; Patient Selection; Pergolide; Pramipexole; Research Design; Sex Factors	2007
Pramipexole-induced antecollis in Parkinson's disease. Journal of the neurological sciences, 2008, Jan-15, Volume: 264, Issue:1-2 Topics: Aged, 80 and over; Benzothiazoles; Dopamine; Dopamine Agonists; Dyskinesia, Drug-Induced; Dystonic Disorders; Electromyography; Female; Head Movements; Humans; Japan; Muscle Tonus; Neck Muscles; Parkinson Disease; Posture; Pramipexole	2008
Burning mouth syndrome responsive to pramipexol. The journal of headache and pain, 2008, Volume: 9, Issue:1 Topics: Aged; Benzothiazoles; Burning Mouth Syndrome; Corpus Striatum; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Female; Humans; Mouth Mucosa; Parkinson Disease; Pramipexole; Prospective Studies; Receptors, Dopamine D2; Restless Legs Syndrome; Substance Withdrawal Syndrome; Treatment Outcome	2008
Medications used to treat Parkinson's disease and the risk of gambling. European journal of neurology, 2008, Volume: 15, Issue:4 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Case-Control Studies; Confidence Intervals; Gambling; Humans; Male; Middle Aged; Odds Ratio; Parkinson Disease; Pramipexole; Retrospective Studies; Review Literature as Topic; Risk	2008
The frequency of cardiac valvular regurgitation in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2008, May-15, Volume: 23, Issue:7 Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence	2008
Pramipexole-induced psychosis in Parkinson's disease. Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:2 Topics: Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Drug Therapy, Combination; Humans; Male; Parkinson Disease; Pramipexole; Psychoses, Substance-Induced	2008
Increased frequency and range of sexual behavior in a patient with Parkinson's disease after use of pramipexole: a case report. The journal of sexual medicine, 2009, Volume: 6, Issue:4 Topics: Aged; Benzothiazoles; Dopamine Agonists; Humans; Male; Paraphilic Disorders; Parkinson Disease; Pramipexole; Sexual Behavior	2009
Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist. Neuroscience letters, 1995, Aug-18, Volume: 196, Issue:1-2 Topics: Animals; Autoradiography; Benzothiazoles; Binding Sites; Brain; Cloning, Molecular; Dopamine Agonists; Male; Parkinson Disease; Pramipexole; Rats; Rats, Sprague-Dawley; Schizophrenia; Tetrahydronaphthalenes; Thiazoles	1995
New dopamine agonists on the horizon. South Dakota journal of medicine, 1997, Volume: 50, Issue:7 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles	1997
Pramipexole marketed for Parkinson's disease. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997, Sep-01, Volume: 54, Issue:17 Topics: Antiparkinson Agents; Benzothiazoles; Drug Approval; Humans; Parkinson Disease; Pramipexole; Thiazoles; United States; United States Food and Drug Administration	1997
Pramipexole and ropinirole for Parkinson's disease. The Medical letter on drugs and therapeutics, 1997, Nov-21, Volume: 39, Issue:1014 Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles	1997
Pramipexole for Parkinson's disease. The Journal of family practice, 1998, Volume: 46, Issue:1 Topics: Adult; Benzothiazoles; Dopamine Agonists; Double-Blind Method; Humans; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Reproducibility of Results; Thiazoles; Treatment Outcome	1998
New anti-parkinsonian drugs. Medicine and health, Rhode Island, 1998, Volume: 81, Issue:7 Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Humans; Indoles; Levodopa; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone	1998
Weight loss is often a problem in late PD. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1998, Volume: 30, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Drug Monitoring; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Thiazoles; Weight Gain	1998
Cost effectiveness of pramipexole in Parkinson's disease in the US. PharmacoEconomics, 1998, Volume: 14, Issue:5 Topics: Antiparkinson Agents; Benzothiazoles; Cost-Benefit Analysis; Humans; Parkinson Disease; Pramipexole; Quality-Adjusted Life Years; Sensitivity and Specificity; Thiazoles; United States	1998
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology, 1999, Jun-10, Volume: 52, Issue:9 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep; Thiazoles; Wakefulness	1999
[High dosage therapy of Parkinson disease. New dopamine agonist pramipexol allows reduction of L-dopa dose down to zero]. Der Nervenarzt, 1999, Volume: 70, Issue:8 Topics: Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pramipexole; Thiazoles	1999
Several classes of new drugs emerging for Parkinson disease. JAMA, 1999, Sep-08, Volume: 282, Issue:10 Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Enzyme Inhibitors; Humans; Indoles; Levodopa; Nitriles; Parkinson Disease; Pramipexole; Thiazoles	1999
Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease. Journal of neurochemistry, 2000, Volume: 74, Issue:4 Topics: 1-Methyl-4-phenylpyridinium; Adenine Nucleotides; Benzothiazoles; Electron Transport; Enzyme Activation; Free Radical Scavengers; Herbicides; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 1; Mitochondria; Mitogen-Activated Protein Kinases; Neuroblastoma; Neurons; NF-kappa B; Oxidative Stress; Parkinson Disease; Peptides; Pramipexole; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-raf; Signal Transduction; Superoxide Dismutase; Thiazoles; Tumor Cells, Cultured	2000
Pleural fibrosis associated with dihydroergocryptine treatment. Acta neurologica Scandinavica, 2000, Volume: 101, Issue:4 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cough; Dopamine Agonists; Dyspnea; Ergolines; Humans; Male; Parkinson Disease; Pramipexole; Pulmonary Fibrosis; Thiazoles	2000
Non-ergot dopamine agonist-induced sleep attacks. Pharmacotherapy, 2000, Volume: 20, Issue:6 Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Thiazoles	2000
Sleep episodes in Parkinson's disease: a wake-up call. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:4 Topics: Accidents, Traffic; Antiparkinson Agents; Benzothiazoles; Humans; Narcolepsy; Parkinson Disease; Pramipexole; Thiazoles	2000
Pramipexole and somnolence. Nursing, 2000, Volume: 30, Issue:8 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Male; Narcolepsy; Parkinson Disease; Pramipexole; Thiazoles	2000
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Archives of neurology, 2000, Volume: 57, Issue:10 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Drug Administration Schedule; Female; Humans; Hypotension, Orthostatic; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Thiazoles	2000
Dopamine agonists in early therapy for Parkinson disease: promise and problems. JAMA, 2000, Oct-18, Volume: 284, Issue:15 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Pramipexole; Thiazoles	2000
Modafinil treatment of pramipexole-associated somnolence. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:6 Topics: Adult; Antiparkinson Agents; Benzhydryl Compounds; Benzothiazoles; Central Nervous System Stimulants; Drug Therapy, Combination; Female; Humans; Modafinil; Narcolepsy; Parkinson Disease; Pramipexole; Thiazoles; Treatment Outcome	2000
Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:10 Topics: Animals; Antioxidants; Benzothiazoles; Cell Line; Cell Survival; Dopamine; Dopamine D2 Receptor Antagonists; Hydrogen Peroxide; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Pramipexole; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles	2000
[Dopaminergic agonists in the treatment of Parkinson's disease]. Revue medicale de Bruxelles, 2000, Volume: 21, Issue:6 Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles	2000
A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cabergoline; Disorders of Excessive Somnolence; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Retrospective Studies; Thiazoles	2001
Antiparkinsonian drugs and "sleep attacks". CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2001, Apr-03, Volume: 164, Issue:7 Topics: Adverse Drug Reaction Reporting Systems; Aged; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Canada; Humans; Indoles; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Thiazoles	2001
Current advances in Parkinson's disease. Trends in neurosciences, 2001, Volume: 24, Issue:7 Topics: Antidepressive Agents; Antiparkinson Agents; Benzothiazoles; Brain Stem; Catechols; Depression; Dopamine Agonists; Humans; Levodopa; Nitriles; Parkinson Disease; Pramipexole; Selegiline; Thiazoles	2001
Efficacy and tolerability of dopamine agonists in a parkinsonian population. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1 Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome	2001
Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma. Journal of neuroscience research, 2002, Feb-15, Volume: 67, Issue:4 Topics: 1-Methyl-4-phenylpyridinium; Alzheimer Disease; Amyloid beta-Peptides; Anti-Bacterial Agents; Aristolochic Acids; Benzothiazoles; Bongkrekic Acid; Brain; Caspase Inhibitors; Caspases; Cell Death; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Humans; Neuroblastoma; Neurodegenerative Diseases; Neurons; Parkinson Disease; Peptide Fragments; Phenanthrenes; Pramipexole; Thiazoles; Tumor Cells, Cultured	2002
Alopecia induced by dopamine agonists. Neurology, 2002, Mar-12, Volume: 58, Issue:5 Topics: Aged; Alopecia; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles	2002
[Dopamine agonist is effective in Parkinson disease not only against tremor. Depression is also improved]. MMW Fortschritte der Medizin, 2002, May-06, Volume: Suppl 2 Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Depressive Disorder; Dopamine Agonists; Humans; Multicenter Studies as Topic; Parkinson Disease; Pramipexole; Thiazoles; Treatment Outcome; Tremor	2002